Institut für Molekulare Infektionsbiologie
Refine
Has Fulltext
- yes (427)
Is part of the Bibliography
- yes (427)
Year of publication
Document Type
- Journal article (297)
- Doctoral Thesis (123)
- Book article / Book chapter (2)
- Conference Proceeding (2)
- Review (2)
- Preprint (1)
Keywords
- Infektionsbiologie (57)
- Escherichia coli (41)
- Candida albicans (25)
- Staphylococcus aureus (16)
- Virulenzfaktor (12)
- Legionella pneumophila (11)
- escherichia coli (11)
- gene expression (11)
- Biofilm (10)
- Genexpression (10)
- virulence (10)
- Immunologie (9)
- RNA-seq (9)
- Virulenz (9)
- expression (8)
- infection (8)
- Biologie (7)
- Malaria (7)
- gene regulation (7)
- identification (7)
- Genregulation (6)
- MRSA (6)
- Molekularbiologie (6)
- Plasmodium falciparum (6)
- antibiotics (6)
- biofilm (6)
- epithelial cells (6)
- pathogens (6)
- resistance (6)
- sRNA (6)
- transcriptome (6)
- Bakterien (5)
- Dendritische Zelle (5)
- Infektion (5)
- Leishmania major (5)
- Molekulargenetik (5)
- Neisseria meningitidis (5)
- Proteasen (5)
- RNA (5)
- Regulation (5)
- Resistenz (5)
- Salmonella (5)
- activation (5)
- antimicrobial resistance (5)
- bacteria (5)
- messenger RNA (5)
- plasmodium falciparum (5)
- regulation (5)
- Adhäsion (4)
- Aspergillus fumigatus (4)
- Biofilmbildung (4)
- Enterobacteriaceae (4)
- Genanalyse (4)
- Hfq (4)
- Immunsystem (4)
- Legionella (4)
- Leishmania (4)
- Pathogenität (4)
- Signaltransduktion (4)
- Staphylococcus epidermis (4)
- Streptococcus pneumoniae (4)
- antibodies (4)
- antisense RNA (4)
- biofilms (4)
- inhibition (4)
- invasion (4)
- macrophages (4)
- signal transduction (4)
- small RNA (4)
- staphylococcus aureus (4)
- synthesis (4)
- transcriptomics (4)
- vancomycin (4)
- Antibiotikum (3)
- Bakterielle Infektion (3)
- COVID-19 (3)
- Campylobacter jejuni (3)
- Dictyostelium (3)
- Dictyostelium discoideum (3)
- Evolution (3)
- Expression (3)
- Grad-seq (3)
- IS256 (3)
- Immunreaktion (3)
- Integrine (3)
- Invasion (3)
- Neisseria gonorrhoeae (3)
- Pathogenitätsinseln (3)
- Phasenvariation (3)
- Probiotikum (3)
- RNA sequencing (3)
- RNA-binding proteins (3)
- RNS (3)
- SARS-CoV-2 (3)
- STEC (3)
- Salmonella Typhimurium (3)
- Salmonella enterica (3)
- Salmonella typhimurium (3)
- Schwamm (3)
- Schwämme (3)
- Small RNA (3)
- Staphylococcus (3)
- Staphylococcus epidermidis (3)
- Stickstoff (3)
- Symbiose (3)
- UPEC (3)
- adaptation (3)
- adhesion (3)
- antibacterial activity (3)
- apoptosis (3)
- autophagy (3)
- bacillus subtilis (3)
- bacteriophage (3)
- biology (3)
- cancer (3)
- candida albicans (3)
- dendritic cells (3)
- fluorescence microscopy (3)
- genes (3)
- genome sequence (3)
- leishmania major (3)
- leishmaniasis (3)
- malaria (3)
- mechanisms (3)
- medicine (3)
- mouse models (3)
- pathogenicity islands (3)
- phase variation (3)
- protein kinase (3)
- regulator genes (3)
- regulatory RNA (3)
- riboswitch (3)
- sequence (3)
- signaling pathway (3)
- stem cells (3)
- substituent (3)
- transcription (3)
- transcription factors (3)
- translation (3)
- transmission (3)
- urinary tract infection (3)
- virulence factors (3)
- 16S rRNA (2)
- 3D tissue model (2)
- Adhärenz (2)
- Agent (2)
- Antibiotika (2)
- Antisense RNA (2)
- Aplysina aerophoba (2)
- Autotransporterprotein (2)
- BNIP3 (2)
- Bacteria (2)
- Bakteriophagen (2)
- Breast-tumors (2)
- Cancer (2)
- Candida (2)
- Candida auris (2)
- Cysteinproteasen (2)
- DNA transcription (2)
- Deletion (2)
- E. coli Nissle 1917 (2)
- E. coli serotype 06 (2)
- Enterococcus faecium (2)
- F8 fimbriae (2)
- Fitness (2)
- Flagelle (2)
- Fluconazol (2)
- Fluconazole (2)
- Geißel <Biologie> (2)
- Gen (2)
- Gene regulation (2)
- Genomik (2)
- Genomvariabilität (2)
- Glykosylierung (2)
- Growth (2)
- HFQ (2)
- Haemophilus influenzae (2)
- Harnwegsinfektion (2)
- Harnwegsinfektionen (2)
- HeLa cells (2)
- Helicobacter pylori (2)
- Hospitalismus <Hygiene> (2)
- Immuntherapie (2)
- Impfung (2)
- In-vivo (2)
- Infection (2)
- Insertionselement (2)
- Kinase (2)
- Leishmaniose (2)
- Lung cancer (2)
- MATQ-seq (2)
- Medizin (2)
- Meeresschwämme (2)
- Metagenomik (2)
- Microarray (2)
- Mip (2)
- NSG (2)
- Nude-mice (2)
- Pathogenitätsinsel (2)
- Pathogens (2)
- Phagozytose (2)
- Pneumokokken (2)
- Poribacteria (2)
- Proteom (2)
- RNA synthesis (2)
- Resistance (2)
- Rhodobacter sphaeroides (2)
- SEQ (2)
- Salmonellosis (2)
- Shigella (2)
- Staphylokokken (2)
- Streptomyces (2)
- T cells (2)
- Therapy (2)
- Toxoplasma gondii (2)
- TraDIS (2)
- Transkriptom (2)
- Transkriptomanalyse (2)
- Transposon (2)
- UTI (2)
- Vibrio cholerae (2)
- adherence (2)
- allelic replacement (2)
- antibiotic resistance (2)
- antifungals (2)
- antigen (2)
- antisense RNAs (2)
- archaea (2)
- bacterial genetics (2)
- biofilm formation (2)
- biofilmformation (2)
- bioluminescence imaging (2)
- biosynthesis (2)
- cell wall (2)
- chaperone (2)
- comparative genomics (2)
- cytokines (2)
- cytotoxicity (2)
- dRNA-Seq (2)
- enterica serovar typhimurium (2)
- epidemiology (2)
- evolution (2)
- flagellum (2)
- gametocyte (2)
- gastric cancer (2)
- gastrointestinal tract (2)
- gene (2)
- gene cloning (2)
- gene expression profiling (2)
- genome (2)
- genome annotation (2)
- glycopeptide antibiotics (2)
- hemolysin (2)
- host cells (2)
- humanized mice (2)
- immune response (2)
- in vitro (2)
- in vivo imaging (2)
- in-vitro (2)
- in-vivo (2)
- inflammation (2)
- inhibitor (2)
- inhibitors (2)
- leishmania (2)
- liraglutide (2)
- magnetic resonance imaging (2)
- marine sponges (2)
- mechanism (2)
- messenger-RNA (2)
- metabolism (2)
- metagenomics (2)
- metastasis (2)
- methionine (2)
- monoclonal antibodies (2)
- monoklonale Antikörper (2)
- mutation (2)
- ncRNA (2)
- neuroimmunology (2)
- neutrophils (2)
- noncoding RNA (2)
- obesity (2)
- oligopeptides (2)
- oncolytic virotherapy (2)
- oncolytic viruses (2)
- parasite (2)
- parasitic diseases (2)
- pathogenicity (2)
- phage (2)
- phylogeny (2)
- plants (2)
- pneumococci (2)
- polycationic peptides (2)
- proteasome (2)
- protein kinases (2)
- proteins (2)
- recombination (2)
- red fluorescent protein (2)
- regulator (2)
- reporter genes (2)
- response regulator (2)
- responses (2)
- ribonucleases (2)
- secretion (2)
- secretion systems (2)
- single-cell RNA-seq (2)
- small RNAs (2)
- small nucleolar RNAs (2)
- strains (2)
- structure-activity (2)
- subunit (2)
- therapy (2)
- transcriptome analysis (2)
- transmission electron microscopy (2)
- tumors (2)
- type VII secretion system (2)
- vaccinia virus (2)
- virulence factor (2)
- (+)-limonene (1)
- (Nucleotide sequence (1)
- 0 antigen (1)
- 18SrRNA (1)
- 19F MR (1)
- 2-component system (1)
- 3D Gewebemodelle (1)
- 3D cell culture (1)
- 3′ UTR (1)
- 5-bromodeoxyuridine (1)
- 5`-Nukleotidase (1)
- 5`-nucleotidase (1)
- 6S RNA (1)
- AAV vector (1)
- ABC-Transporter (1)
- AMP-activated kinases (1)
- APEC (1)
- ATG (1)
- ATG8 (1)
- AcrAB-TolC efflux pump (1)
- Adaptorproteine (1)
- Adenylatkinase (1)
- Adherence (1)
- Adhesion (1)
- Adhäsine (1)
- Adhäsion <Pathologie> (1)
- Alkyltransferase Ribozyme SAMURI (1)
- Ammoniakstoffwechsel (1)
- Amoebapor-Proteine (1)
- Amoebapores (1)
- Angeborene Immunität (1)
- Anopheles stephensi (1)
- Antibiotic (1)
- Antibiotics (1)
- Antigenpräsentation (1)
- Antikörper (1)
- Antikörper-Antwort (1)
- Antimicrobial activity (1)
- Antimykotikum (1)
- Apicomplexan (1)
- Apoptose (1)
- Apoptosis (1)
- Archaea (1)
- Array (1)
- Arzneimitteldesign (1)
- Arzneimittelresistenz (1)
- Aspartatprotease (1)
- Asthma (1)
- Asymptomatic Bacteriuria (1)
- Attenuierung (1)
- Autophagie (1)
- Autophagiescore (1)
- Autotransporter (1)
- Avirulent Salmonella (1)
- B1 Mapping (1)
- BCG (1)
- BT_1884 (1)
- Bacillus subtilis (1)
- Bacterial conjugation (1)
- Bacterial infection (1)
- Bacterial pathogens (1)
- Bacteriaophage AR9 (1)
- Bakterielle Konjugation (1)
- Bakteriophage (1)
- Bakteriophage K139 (1)
- Bestimmung (1)
- Biofilm formation (1)
- Bioinformatics (1)
- Biology (1)
- Biosynthese der aromatischen Aminosäuren (1)
- Bloch Siegert (1)
- Blood-brain barrier (1)
- Blutgefäß (1)
- Bordeiella pertussis (1)
- Bovine Mastitis (1)
- Bovis (1)
- Bradyrhizobium (1)
- Bronchialasthma (1)
- C-6-H (1)
- C-Terminus (1)
- CDR1-Effluxpumpe (1)
- CEACAM (1)
- CEACAM3 (1)
- CEACAMs (1)
- COX-2 (1)
- CRISPR-Cas system (1)
- CRISPRs (1)
- CTSE (1)
- CUL4-DDB1 ubiquitin ligase (1)
- Calcineurin (1)
- Calcium (1)
- Carbonyl-Reductase <NADPH> (1)
- Carbonylreduktase (1)
- Carcino-embryonales Antigen (1)
- Carcinoma (1)
- Cas9 (1)
- Caspasen (1)
- Cathepsin E (1)
- Cell binding (1)
- Characterization (1)
- Chemical modification (1)
- Chemokine (1)
- Chemotherapy (1)
- Chlamydia (1)
- Chlamydia pneumoniae (1)
- Chlamydien (1)
- Chlamydophila pneumoniae (1)
- Citrobacter freundii (1)
- Clp <Protease> (1)
- ClpP (1)
- ClpX (1)
- Colibactin (1)
- Combination therapy (1)
- Complexome (1)
- Conjugation (1)
- CpG (1)
- Crohns-disease (1)
- CsrA (1)
- Cutaneous leishmaniasis (1)
- Cyanobacteria (1)
- Cyanobakterien (1)
- Cyclophosphamide (1)
- Cystic-fibriosis (1)
- DASH (1)
- DNA (1)
- DNA glycosation (1)
- DNA lang range mapping (1)
- DNA methylation (1)
- DNA methylferase homolog (1)
- DNA-Array (1)
- DNA-array (1)
- Darm (1)
- Darmflora (1)
- Defensine (1)
- Deletionsmutante (1)
- Deletionsrate (1)
- Demospongiae (1)
- Denaturierende Gradienten-Gelelektrophorese (1)
- Denaturing Gradient Gel Electrophoresis (1)
- Dendritic cell (1)
- Dendritic cells (1)
- Dendrtitischer Zellen (1)
- Dextran sulphate (1)
- Dezentralisierung (1)
- Diarrhea (1)
- Dimerisierung (1)
- Disease gene prioritization (1)
- Division (1)
- Drosophila (1)
- Drug resistance (1)
- Dual 3'seq (1)
- Dual RNA-seq (1)
- E. coli (1)
- E. coli hemolysin (1)
- E. coli virulence (1)
- E.coli (1)
- E.coli Nissle 1917 (1)
- ECM (1)
- EGFP (1)
- EHEC (1)
- ELISA (1)
- ER (1)
- ESAT‐6‐like secretion system (1)
- ESS (1)
- EZM (1)
- Efflux pump (1)
- Effluxpumpen (1)
- Eingeweidewürmer (1)
- Einzelzell-Genomik (1)
- Eisen (1)
- Eisenmangel (1)
- Elektronenmikroskopie (1)
- Elektronisches Publizieren (1)
- Elektroporation (1)
- Entamoeba histolytica (1)
- Enterhämorrhagische Escherichia coli (1)
- Enterica serovar typhimurium (1)
- Enteritis (1)
- Enterococcus faecalis (1)
- Enterohaemorrhagic Escherichia coli (1)
- Environmental isolate (1)
- Epstein-Barr virus (1)
- Erwachsener (1)
- Erwinia amylovora (1)
- EsaA (1)
- Escherichia coli strains (1)
- Escherichia coli-Hfq (1)
- Escherichia coli-Stämme (1)
- Escherichia-coli K-12 (1)
- Ethiopia (1)
- Evasionsmechanismen (1)
- ExPEC (1)
- Excision (1)
- Expressionsgenbank (1)
- Extracellular matrix (1)
- Extrazelluläre Matrix (1)
- F-19 MRI (1)
- F1 (1)
- FACS-Analyse (1)
- FACS-analysis (1)
- FAK (1)
- Factor H (1)
- Family (1)
- Fibronectin (1)
- Fibronektin (1)
- Fimbria (1)
- Fimbriae (1)
- FinO family (1)
- Fischerella sp. (1)
- Fitneßfaktor (1)
- Flavomycin (1)
- Flavophospholipol (1)
- Fluoreszenz-in-situ-Hybridisierung (1)
- Fluoreszenzmikroskopie (1)
- Foc protein (1)
- Freilebende Amöben (1)
- Ftsz (1)
- Fusobacterium nucleatum (1)
- GFP (1)
- GFP-Reportergen (1)
- GFP-reportersystem (1)
- GI-101A tumor xenografts (1)
- GLP-1 (1)
- GLV-1 h153 (1)
- GLV-1H68 (1)
- GO1 (1)
- Gametogenese (1)
- Gametozyt (1)
- Gene (1)
- Gene cloning (1)
- Gene expression (1)
- Gene mapping (1)
- Gene-expression (1)
- Gene-transfer (1)
- Genetik (1)
- Genome analysis (1)
- Genome re-annotation (1)
- Genomic profile (1)
- Genomorganisation (1)
- Genomplastizität (1)
- Genomvaribilität (1)
- Gentransfer (1)
- Germany (1)
- Gesundheitssektorreform (1)
- GibS (1)
- Gifsy-1 (1)
- Glatte Muskulatur (1)
- Glykosyltransferase (1)
- Gram-positive bacteria (1)
- Grundsubstanz (1)
- Grün fluoreszierendes Protein (1)
- H-NS (1)
- HBD2 (1)
- HD5 (1)
- HGT (1)
- HIV (1)
- Haemolysin (1)
- Haloferax volcanii (1)
- Halogenase (1)
- Harnwegsinfekt (1)
- Harnwegskrankheit (1)
- Helicobacterpylori (1)
- Helminthen (1)
- Helminths (1)
- Hemolysin excretion (1)
- Herzmuskel (1)
- Hidden-Markov-Modell (1)
- Hirnhautentzündung (1)
- Histatin 5 (1)
- Histon-ähnliche Proteine (1)
- Histone-like proteins (1)
- Homology (1)
- Horizontaler Gentransfer (1)
- Hospital water system (1)
- Host adaptation (1)
- Host cells (1)
- Human-pathogenic (1)
- Hämolysin (1)
- IL-12 production (1)
- IL-4 (1)
- IL-4 Rezeptor alpha (1)
- IL-4 receptor alpha chain (1)
- IS100 (1)
- ITAM (1)
- IcaR (1)
- Ileal Crohns-disease (1)
- Images (1)
- Immunantwort (1)
- Immunbiologie (1)
- Immunisierung (1)
- Immunohistochemistry; Immunogold-silver staining; FITC- anti-FITC system; Leucocyte subpopulations; Two-color staining (1)
- Immunotherapy (1)
- Impfstoff (1)
- Impfungen (1)
- In Vivo Expressionstechnologie (1)
- In vivo (1)
- In-vitro (1)
- Inactivation (1)
- Infection models (1)
- Infektionsbildgebung (1)
- Inflammation (1)
- Inhibitor (1)
- Inhibitoren (1)
- Insertionssequenzen (1)
- Integrin (1)
- Interferon <gamma-> (1)
- Interleukin 12 (1)
- Internal transcription start site (1)
- Invasion genes (1)
- Ire1 (1)
- Iron-oxide (1)
- Iron-uptake (1)
- IsaA (1)
- IsaB (1)
- Isolation and Characterization (1)
- IsrK (1)
- K279a (1)
- Kapsel (1)
- Katheter (1)
- Kernspintomografie (1)
- KhpB protein (1)
- Kinasen (1)
- Klebsiella pneumoniae (1)
- Kleine Proteine (1)
- Klonierungsvektoren (1)
- Koevolution (1)
- Kohlenhydrate (1)
- Kollagen (1)
- Komplement <Immunologie> (1)
- Kontrastmittel (1)
- Krankheitsübertragung (1)
- Krebs <Medizin> (1)
- Kultivierung (1)
- LPS (1)
- Laminin (1)
- Langerhans cell (1)
- Leaderless transcript (1)
- Legiolysin (1)
- Legionella ssp. (1)
- Legionellae (1)
- Legionellen (1)
- Legionnaires' disease (1)
- Legionärskrankheit (1)
- Leishmanien (1)
- Lepra (1)
- Lesions (1)
- Level (1)
- Library of Phytochemicals (1)
- Library of plant species (1)
- Lichtschutz (1)
- Listeria monocytogenes (1)
- Lungenkrebs (1)
- Lysis (medicine) (1)
- Lysophospholipase (1)
- MACE (1)
- MDR1 (1)
- MET-T-box riboswitch (1)
- MI-2/NURD complex (1)
- MIP (1)
- MITE (1)
- MRI reporter (1)
- MRR1 (1)
- MRSA - methicillin-resistant Staphylococcus aureus (1)
- MT02 (1)
- MTOR (1)
- MVT (1)
- Macrophage (1)
- Maintenance (1)
- Makrophage (1)
- Makrophagen (1)
- Malaria tropica (1)
- Malariamücke (1)
- Malignant effusion (1)
- Mastitis (1)
- Mat Fimbrien (1)
- Mat fimbriae (1)
- Mcl-1 (1)
- Medicine (1)
- Medizinische Mikrobiologie (1)
- Membraninteraktionen (1)
- Metalloprotease (1)
- Methanosarcina mazei (1)
- Methioninbiosynthese (1)
- MgrB (1)
- MicF (1)
- Mice (1)
- MicroRNAs (1)
- Microscopy (1)
- Microwave Assisted Extraction (1)
- Mig1 (1)
- Mikroarray (1)
- Mikroorganismus (1)
- Mikroskopie (1)
- Minor subunits (1)
- Mitteldarm (1)
- Modell (1)
- Molekulare Infektionsbiologie (1)
- Moraxella catarrhalis (1)
- Mosquito (1)
- Mouse (1)
- Mrr1 (1)
- Multiadhäsionsdomänenproteine (1)
- Multidrugresistant (1)
- Multiproteinkomplex (1)
- Mutant (1)
- Mycobacterium (1)
- Mykose (1)
- Mäuse (1)
- Mücke (1)
- N-glycans (1)
- NAD (1)
- NAFLD (1)
- NAS (1)
- NASH (1)
- ND10 complex (1)
- NF-KAPPA-B (1)
- NK cells (1)
- NOTCH (1)
- NRG1 (1)
- NSG-SGM3 (1)
- Nachweis (1)
- Nanotubes (1)
- Naphthalinderivate (1)
- Nature-Insipired Synthesis (1)
- Nck (1)
- Neugeborenes (1)
- Nichtrezeptor-Tyrosinkinasen (1)
- Nitrifikation (1)
- Nitrogen (1)
- Nitroreduktase (1)
- Nodule (1)
- Non-coding RNA (1)
- Non-coding RNAs (1)
- Nonpathogenic Escherichia-coli (1)
- Nosocomial Infections (1)
- Nosokomiale Infektionen (1)
- OLFM4 (1)
- Oberflächenproteine der Sexualstadien (1)
- Oligopeptide (1)
- Oncolytic virotherapy (1)
- One Health (1)
- Opa (1)
- Open Science (1)
- Organoids (1)
- Orthogonal field attenuation gel electrophoresis (1)
- OxyR (1)
- P-fimbriae (1)
- P. falciparum (1)
- PCR (1)
- PCR detection system (1)
- PCR-Nachweissystem (1)
- PEGylation (1)
- PETRI-seq (1)
- PFS25 (1)
- PIA/ica (1)
- PLAP (1)
- PML (1)
- PML nuclear-bodies (1)
- PPGPP (1)
- PPIasen (1)
- PPIases (1)
- PSI-blast (1)
- PYY3-36 (1)
- Paeonia (1)
- Pan1 (1)
- Parasit (1)
- Parkinson's disease (1)
- Particles (1)
- Pathogene Bakterien (1)
- Pathogenicity (1)
- Pathogenicity islands (1)
- Pathogenitätsfaktoren (1)
- Pathologie (1)
- Pathology (1)
- Peptidtransport (1)
- Perfluorkarbon (1)
- PfAMA1 (1)
- PfCCp protein (1)
- Pflanzen (1)
- Pfs230 (1)
- Phage (1)
- Phageninduktion (1)
- Phagocytosis (1)
- Phagosom (1)
- Phagosomen (1)
- Phospholipase (1)
- Pigmentierung (1)
- Pilus (1)
- Pilzinfektionen (1)
- PknB (1)
- Plant extracts (1)
- Plants (1)
- Plasmid (1)
- Plasmidcharakterisierung (1)
- Plasmodium (1)
- Poly-(ADP-Ribose)Polymerase (1)
- Polyketid (1)
- Polyketid-Synthasen (1)
- Polymeric Immunoglobulin receptor (1)
- Polysaccharide intercellular adhesin (PIA) (1)
- Poribakterien (1)
- Porifera (1)
- Posttranskriptionelle Regulation (1)
- Privatisierung (1)
- ProQ (1)
- Probiotic (1)
- Promoter (1)
- Promoter prediction (1)
- Proteaseinhibitor (1)
- Proteases (1)
- Protein (1)
- Protein function prediction (1)
- Proteine (1)
- Proteins (1)
- Proteogenomics (1)
- Proteolyse (1)
- Proteolysis (1)
- Proteomanalyse (1)
- Proteomics (1)
- Pseudomonas (1)
- Pseudomonas aeruginosa (1)
- Pseudomonas-aeruginosa (1)
- Pyrophosphatase (1)
- Quartäre Bisnaphthalimide (1)
- Quaternary Bisnaphthalimide (1)
- Quinupristin/Dalfopristin (1)
- RFP (1)
- RNA Abbau (1)
- RNA CHAPERONE HFQ (1)
- RNA chaperone Hfq (1)
- RNA decay (1)
- RNA denaturation (1)
- RNA expression (1)
- RNA sequence analyses (1)
- RNA structure (1)
- RNA-Seq (1)
- RNA-binding protein (1)
- RNA-polymerase-I (1)
- RNA-polymerase-II (1)
- RNA-sequencing (1)
- RNAseq (1)
- RNS-Bindungsproteine (1)
- RNS-Spleißen (1)
- RNase E (1)
- RNase III (1)
- ROS (1)
- RSC Chromatin Remodeling Komplex (1)
- RSC chromatin remodeling complex (1)
- RTS,S/AS01 malaria vaccine (1)
- RYGB (1)
- Rapid evolution (1)
- Rats (1)
- Recombinant defensins (1)
- Recombinant vaccinia (1)
- Recombination directionality factor (1)
- Regression (1)
- Regulatorgene (1)
- Rekombinante DNS (1)
- RelA (1)
- Reportergene (1)
- Reproducibility challenges (1)
- Resistenzen (1)
- Resistenzmechanismen (1)
- Restenose (1)
- Rezeptor (1)
- Ribosome profiling (1)
- Roux-en-Y gastric bypass surgery (1)
- Rubritalea (1)
- S fimbrial adhesin (Sfa) (1)
- S-Fimbriae (1)
- S-fimbria (1)
- S-fimbriae (1)
- S. aureus (1)
- S. epidermidis (1)
- S.aureus (1)
- SAP2 (1)
- SCCmec (1)
- SER/THR kinase (1)
- SM-like protein (1)
- SNF1 (1)
- STP1 (1)
- SUBSP carotovora (1)
- SWI2/SNF2-like protein (1)
- Salmonella enterica Typhimurium strain SL1344 (1)
- Salmonella-enteritidis (1)
- Salmonella-typhimurium (1)
- Saposin-like proteins (1)
- Saposin-ähnliche Proteine (1)
- Schistosoma japonicum; Egg antigen; Carbohydrate epitope; Circumoval precipitin test; Immunoassay (1)
- SdsR (1)
- Secretion (1)
- Sekretom (1)
- Sekundärmetabolit (1)
- Selektionsmarker (1)
- Selektivität (1)
- Sequence Analysis (1)
- Sequence identity (1)
- Sequencing (1)
- Sequenzanalyse (1)
- Serinprotease (1)
- Serogroup (1)
- Serratia marcescens (1)
- Seuchenkontrolle (1)
- Sexualentwicklung (1)
- Sexualstadien (1)
- Sexuelle Entwicklung (1)
- Shiga toxin-producing Escherichia coli (1)
- Shiga-Toxin 2 (1)
- Shigellosis (1)
- Signalkette (1)
- Site-specific RNA labelling (1)
- Snf1 (1)
- Soft-tissue infection (1)
- Southern hybridization (1)
- Speichel (1)
- Splicing (1)
- Sponge diseases (1)
- Sponges (1)
- Src-Proteine (1)
- Staphylococcal infection (1)
- Staphylococcus aureus USA300 (1)
- Staphylococcus aureus immune response (1)
- Staphylococcus-aureus (1)
- Stenotrophomonas maltophilia (1)
- Stickstoff-Verwertung (1)
- Stickstoffmetabolismus (1)
- Stickstoffversorgung (1)
- Stickstoffwechsel (1)
- Stp (1)
- StpA (1)
- Strain nissle-1917 (1)
- Strains (1)
- Streptococcus faecium (1)
- Streptomyceten (1)
- Streptomycetes (1)
- Stringent response (1)
- Stringente Antwort (1)
- Stringente Kontrolle (1)
- Stx2 (1)
- Stx2-Mutante (1)
- Stx2-mutant (1)
- Sugar-transport (1)
- Suicide vector (1)
- SuperSAGE (1)
- Symbionts (1)
- Synthese (1)
- Synthesis (1)
- Systematik (1)
- T cell (1)
- T helper cell (1)
- T lymphocytes (1)
- T-Zellen (1)
- T-cell (1)
- TEM (1)
- TH1/TH2 (1)
- TRNA(ASP) (1)
- Target (1)
- Taufliege (1)
- Tet-On system (1)
- Th1 immunantwort (1)
- Th1 response (1)
- Thiostrepton (1)
- Thrombospondin (1)
- Thrombospondin-1 (1)
- Tissue (1)
- Tissue Engineering (1)
- Toll-like receptors (1)
- Toxicity ; plasmids (1)
- Toxoplasmase gondii (1)
- Tracking (1)
- Transcription (1)
- Transcription profiling (1)
- Transcription start site (1)
- Transcriptome (1)
- Transcriptome analysis (1)
- Transfektion (1)
- Transfer-RNA modification (1)
- Transkiptom (1)
- Transkription <Genetik> (1)
- Transkriptionsfaktor (1)
- Translation efficiency (1)
- Transmissionsblockierende Impfstoffe (1)
- Transmissionsblockierende Vakzine (1)
- Transporter (1)
- Transposase (1)
- Transposon insertion sequencing (1)
- Typ 1 Fimbrien (1)
- Typhimurium (1)
- UKZ (1)
- UME6 (1)
- UPECs (1)
- Urinary tract (1)
- Urogenitalsystem (1)
- Uropatbcgenie E. coli (1)
- VEGF (1)
- Vaccines (1)
- Vaccinia virus (1)
- Vakuole (1)
- Valeriana wallichii (1)
- VanA (1)
- Vancomycin (1)
- Variability (1)
- Variants (1)
- Vascular endothelial Growth Factor (1)
- Verrucomicrobia (1)
- Vertikale Weitergabe (1)
- Virologie (1)
- Virtual Research Environment (1)
- Virulence (1)
- Virulenz-assoziierte Gene (1)
- Virulenzfaktoren (1)
- Virulenzfaktors Mip (1)
- Virulenzmechanismen (1)
- Virusinfektion (1)
- WD40 (1)
- White-Opaque Switching (1)
- Wirtsspezifität (1)
- Wirtszelle (1)
- Yeast (1)
- Yersinia (1)
- Yersinia-pseudotuberculosis (1)
- YoelII-Nigeriensis (1)
- Ypk1 (1)
- Zellfilamente (1)
- Zink-Cluster-Transkriptionsfaktoren (1)
- Zink-Finger-Proteine (1)
- Zoonotisches Risiko (1)
- abscesses (1)
- acetivorans C2A (1)
- acetones (1)
- acid (1)
- acrican trypanosomes (1)
- actinomycetes (1)
- activation mechanism (1)
- acute myeloid leukemia (1)
- adaptation phase (1)
- adenylate kinase (1)
- adults (1)
- agr (1)
- agroinfiltration (1)
- albicans (1)
- alignment (1)
- alignment clustering (1)
- alpha defensins (1)
- alternative pig farming (1)
- alveolar fibrosis (1)
- alveolar regeneration (1)
- ammonium (1)
- ammonium permease (1)
- angeborene Immunabwehr (1)
- animal model (1)
- animal models (1)
- animal-model (1)
- annotation (1)
- anti-biofilm (1)
- anti-schistosomal activity (1)
- anti-sigma factor (1)
- antibacterial (1)
- antibacterial drug resistance (1)
- antibacterials (1)
- antibiotic (1)
- antibiotic production (1)
- antifungal drug (1)
- antigen-presenting cells (1)
- antigenic variation (1)
- antimicrobial activity (1)
- antimicrobial peptides (1)
- antimicrobials (1)
- antitermination (1)
- arabidopsis (1)
- aromatic amino acid biosynthesis (1)
- artifizielle Aktivierung (1)
- aspartic protease (1)
- aspergillosis (1)
- aspergillus fumigatus (1)
- atypical tetracyclines (1)
- automation (1)
- autophagy-related (1)
- autotransporter (1)
- autotransporter protein (1)
- azobenzenes (1)
- bac-genomics-scripts (1)
- bacterial (1)
- bacterial biofilms (1)
- bacterial genomes (1)
- bacterial genomics (1)
- bacterial immune evasion (1)
- bacterial infection (1)
- bacterial infection model (1)
- bacterial lipoproteins (1)
- bacterial live vector (1)
- bacterial migration (1)
- bacterial pathogen (1)
- bacterial physiology (1)
- bacterial resistance (1)
- bacterial secretion (1)
- bacterial signal molecule (1)
- bacterial transcription (1)
- bacterial uptake (1)
- bacterial virulence (1)
- bacteriology (1)
- bakterielle Aufnahme (1)
- bakterieller Lebendvektor (1)
- balancing selection (1)
- beta-glucuronidase (1)
- beta-lactamases (1)
- binding (1)
- binding protein HFQ (1)
- biocide polyhexamethylene biguanide (1)
- biofilm regulation (1)
- biolog (1)
- biological scaffold (1)
- bioluminescence (1)
- bioorthogonal SAM analogue ProSeDMA (1)
- biophotonic imaging (1)
- biosynthetic gene-cluster (1)
- blood (1)
- blood-brain barrier (1)
- blood-cerebrospinal fluid barrier (1)
- blood-stream forms (1)
- brain endothelial cells (1)
- breast-tumors (1)
- broad-spectrum antibiotics (1)
- burkholderia cenocepacia (1)
- caffeic acid bornyl ester (1)
- calcineurin (1)
- campestris PV vesicatoria (1)
- campylobacter (1)
- cancer microenvironment (1)
- cancer treatment (1)
- cancers and neoplasms (1)
- candida (1)
- capsule (1)
- carbon metabolism (1)
- carbonyl reductase (1)
- carcinoma (1)
- carcinomas (1)
- cardiac remodeling (1)
- carvacrol (1)
- caspases (1)
- casposon (1)
- catalytic (1)
- cell cultures (1)
- cell cycle (1)
- cell death (1)
- cell differentiation (1)
- cell filaments (1)
- cell fusion (1)
- cell signalling (1)
- cell vaccines (1)
- cell wall synthesis (1)
- cell-cycle arrest (1)
- cell-line (1)
- cepedia complex (1)
- chaperone HFQ (1)
- chaperone Hfq (1)
- characterization (1)
- chelocardins (1)
- chemokine (1)
- children (1)
- chlamydomonas flagella (1)
- chromosomal genes (1)
- circular intermediates (1)
- citral (1)
- citrus (1)
- clinical (1)
- clinical isolates (1)
- clonal analysis (1)
- cloning vectors (1)
- co-infection (1)
- coagulase-negative staphylococci (1)
- coevolution (1)
- cold-shock protein (1)
- coli nissel 1917 (1)
- collaboratories (1)
- colony morphotypes (1)
- colorectal (1)
- colorectal cancer (1)
- community settings (1)
- comparative sequence analysis (1)
- complete genome sequence (1)
- complex (1)
- components (1)
- conditional expressionsystem (1)
- conditional mutants (1)
- conditional promoter replacement (1)
- conservation (1)
- conserving surgery (1)
- consesus (1)
- contact lens (1)
- controllability (1)
- cost-effectiveness (1)
- crystal structure (1)
- crystal-structures (1)
- cutane leishmaniasis (1)
- cysteine preoteases (1)
- cytolethal distending toxin (1)
- dRNA-seq (1)
- dark-matter (1)
- database (1)
- decay (1)
- decentralization (1)
- deep sequencing (1)
- deepSuperSAGE (1)
- deficient mice (1)
- deletion (1)
- deletion mutagenesis (1)
- deletion rate (1)
- demospongiae (1)
- dendritische Zelle (1)
- dependent gene-expression (1)
- dependent protein-kinase (1)
- derivatives (1)
- detection (1)
- determines pathgenicity (1)
- diagnostic Microarray (1)
- diagnostischer Microarray (1)
- diarrhea (1)
- differential (1)
- dimerization (1)
- directional RNA-Seq (1)
- disease (1)
- disease control (1)
- diseases of the nervous system (1)
- dogs (1)
- domain (1)
- domain genes A3(2) (1)
- down regulation (1)
- drosophila (1)
- drospophila (1)
- drug (1)
- drug design (1)
- drug repurposing (1)
- drug resistance evolution (1)
- drug-delivery systems (1)
- dual RNA-seq (1)
- dual function (1)
- dynamic programming (1)
- ecoli_VF_collection (1)
- efflux pump (1)
- eigenvector centrality (1)
- electron tomography (1)
- electrophilic stress (1)
- elements (1)
- emotional behavior (1)
- emulsions (1)
- endocytosis (1)
- endoribonuclease (1)
- energy metabolism (1)
- enteric pathogens (1)
- enterica serovar thphimurium (1)
- entero-aggregative-haemorrhagic Escherichia coli (EAHEC) (1)
- enterobacteria (1)
- enterococci (1)
- environment (1)
- environmental genomics (1)
- environmental regulation (1)
- enzyme APOBEC3G (1)
- enzyme-linked immunoassays (1)
- ephitelial cells (1)
- epithelial-mesenchymal transition (1)
- epithelium (1)
- escherichia coli K-12 (1)
- essential gene (1)
- essential genes (1)
- essential oils (1)
- ethanol (1)
- eugenyl cinnamate (1)
- eukaryotes (1)
- evasion mechanisms (1)
- experimental visceral leishmaniasis (1)
- expression library (1)
- expression mutants (1)
- extracellular domain (1)
- extracellular enzymes (1)
- extraintestinal E. coli (1)
- extraintestinal isolates (1)
- extraintestinal pathogener E. coli (1)
- extrapulmonary (1)
- falciparum (1)
- family (1)
- fatty acids (1)
- fibronectin (1)
- fibronectin-binding protein (1)
- filamentous Salmonella Typhimurium (1)
- finder using symmetrical best hits (1)
- fitness (1)
- fitness factor (1)
- flagella (1)
- flagellar basal body (1)
- flavophospholipol (1)
- flexible genome (1)
- flexibler Teil des Genoms (1)
- flotillin (1)
- flow cytometry (1)
- fluconazole resistance (1)
- fluorescence imaging (1)
- fluorescence in situ hybridization (1)
- fluorescent probe (1)
- fluorescent protein (1)
- fluoreszierende in situ Hybridisierung (1)
- flux balance analysis (1)
- food industry (1)
- fostamatinib (1)
- free-living freshwater amoebae (1)
- freilebende Süßwasseramöben (1)
- functional genomics (1)
- fungal genetics (1)
- fungal infections (1)
- fungal pathogens (1)
- fungi (1)
- fungus (1)
- gallotannins (1)
- gamete (1)
- gametes (1)
- gametocytogenesis (1)
- gametogenesis (1)
- gastric bypass (1)
- gastrointestinal disease (1)
- gastrointestinal infections (1)
- gene expression heterogeneity (1)
- gene family targeting (1)
- gene probes (1)
- gene therapy (1)
- gene variability (1)
- gene-cloning (1)
- gene-cluster (1)
- gene-expression (1)
- general stress response (1)
- genetic modification (1)
- genetic organization (1)
- genetic recombination (1)
- genetic transcription (1)
- genome organization (1)
- genome plasticity (1)
- genome variability (1)
- genome wide (1)
- genome-wide analysis (1)
- genomes (1)
- genomic deletions (1)
- genomic islands (1)
- genomic libraries (1)
- genomic library construction (1)
- genomic variability (1)
- genomics (1)
- genomische Variabilität (1)
- genomvariability (1)
- genus Aspergillus (1)
- geometry (1)
- germination (1)
- global gene expression (1)
- glv-1h68 (1)
- glycolysis (1)
- glycosome (1)
- glycosyl phosphatidyl-inostitols. (1)
- gonococci (1)
- gram-negative bacteria (1)
- green fluorescent protein (1)
- growth (1)
- growth rate control (1)
- haemoproteus-columbae (1)
- halstedii JM8 (1)
- harmonia axyridis (1)
- harmonine (1)
- health sector reform (1)
- hela cells (1)
- helicobacter (1)
- hemolytic-uremic syndrome (1)
- heterogeneity (1)
- heterologous production (1)
- heteropathogenicity (1)
- hexose transporter (1)
- hidden markov-models (1)
- high-throughput sequencing (1)
- histidine kinases (1)
- histology (1)
- homologs (1)
- homology search (1)
- horizontal gene transfer (1)
- hos tcells (1)
- host (1)
- host (organism) (1)
- host colonization (1)
- host pathogen interaction (1)
- host specificity (1)
- host-cell invasion (1)
- host-pathogen-interaction (1)
- human factor H (1)
- human herpesvirus 6 (1)
- human host cells (1)
- human macrophages (1)
- human pathogenic fungi (1)
- human pathogens (1)
- human sodium iodide symporter (hNIS) (1)
- humane Wirtszellen (1)
- humaner Faktor H (1)
- humanized hemato-lymphoid mice (1)
- hybrid (1)
- hydrogen regulation (1)
- hydrogen-peroxide (1)
- hyperexpression techniques (1)
- hypersensitive response (1)
- hyperthermophile (1)
- hyphae (1)
- hypothalamic gene expression (1)
- ica (1)
- ica Operon (1)
- ica-Operon (1)
- icaADBC (1)
- immune System (1)
- immune sytem (1)
- immunity (1)
- immunization (1)
- immunodeficiency-virus type-1 (1)
- immunodominant antigens (1)
- immunodominante Antigene (1)
- immunsystem (1)
- immuntherapy (1)
- in vivo (1)
- in vivo Monitoring (1)
- in vivo expression technology (1)
- in vivo monitoring (1)
- in-vitro propagation (1)
- inactivation (1)
- infection biology (1)
- infectious disease (1)
- inflammatory bowel disease (1)
- inflammatory-bowel-disease (1)
- innate Immunity (1)
- insect immunity (1)
- insertion sequences (1)
- insights (1)
- integration (1)
- integrin (1)
- interaction surfaces (1)
- interactome (1)
- interferon-gamma (1)
- intermediate host (1)
- internalization (1)
- intervention strategies (1)
- interview (1)
- intestinal enteroids (1)
- intracellular multiplication (1)
- intracellular pathogen (1)
- intracellular pathogens (1)
- intrazelluläre Vermehrung (1)
- iron (1)
- iron limitation (1)
- island (1)
- isolation (1)
- kinase (1)
- kingdom (1)
- konditionales Expressionssystem (1)
- kutane Leishmaniose (1)
- latency (1)
- lead structure (1)
- leaves (1)
- legionella pneumophila (1)
- leishmaniose (1)
- leprosy (1)
- leuX-tRNA (1)
- libraries (1)
- library screening (1)
- life cycle (1)
- light protection (1)
- lines (1)
- linker influence (1)
- lipids (1)
- liquid chromatography-mass spectrometry (1)
- listeria monocytogenes (1)
- livestock-associated staphylococci (1)
- locus (1)
- luciferase (1)
- lux (1)
- lymph nodes (1)
- lymphadenitis (1)
- lysogen (1)
- lytic replication (1)
- mC (1)
- mCherry (1)
- macrophage infection (1)
- malaria parasite (1)
- malaria vaccine (1)
- maps (1)
- marine Schwämme (1)
- mass spectrometry (1)
- mastectomy (1)
- mastitis-associated Escherichia coli (MAEC) (1)
- maternal separation (1)
- mating (1)
- maturation (1)
- mechanism of resistance (1)
- mechanisms of disease (1)
- membrane (1)
- membrane interactions (1)
- membrane proteins (1)
- membrane vesicles (1)
- membrane-protein topology (1)
- meningococcus (1)
- merozoite (1)
- messanger RNA (1)
- messenger-RNA decay (1)
- meta-analysis based orthology (1)
- metabolic adaptation (1)
- metallo protease (1)
- metastases (1)
- methanoarchaea (1)
- methanol methyltransferase isozymes (1)
- methanosarcina mazei GO1 (1)
- methicillin (1)
- methionine biosynthesis (1)
- miRNAs (1)
- mice (1)
- microRNAs (1)
- microSPLiT (1)
- microarray (1)
- microbial diversity (1)
- microbial ecology (1)
- microbiology (1)
- microbiome (1)
- microbiota (1)
- microenvironment (1)
- microneme (1)
- microtubule motor (1)
- midgut (1)
- migration (1)
- mikrobielle Diversität (1)
- mikrobielle Ökologie (1)
- mitochondria (1)
- model (1)
- modulation of virus replication (1)
- molecular epidemiology (1)
- molecular evolution (1)
- monocyte (1)
- morphogenesis (1)
- mouse (1)
- mucosal inflammation (1)
- multidrug-resistant bacteria (1)
- multivesicular tubule (1)
- murine leishmaniasis (1)
- murines Modell der aufsteigenden Harnwegsinfektion (1)
- mycobacterium tuberculosis (1)
- mycobacterium-tuberculosis (1)
- myelin biology and repair (1)
- myeloma (1)
- nanotubes (1)
- natively unstructured protein (1)
- natural antisense transcripts (1)
- natural transformation (1)
- necrosis-factor-alpha (1)
- neisseria gonorrhoeae (1)
- network biology (1)
- nitrification (1)
- nitrogen (1)
- nitrogen regulation (1)
- nitrogen utilization (1)
- nitroreductase (1)
- non-aureus staphylococci (1)
- non-coding RNA (1)
- noncoding RNAs (1)
- nondocing RNA (1)
- norovirus (1)
- northern blotting (1)
- nosocomial infections (1)
- nosocomial pathogen (1)
- nosokomiale Infektionen (1)
- nucleotide sequence (1)
- nude-mice (1)
- nutrients (1)
- olfactomedin 4 (1)
- oligopeptide transport (1)
- oncolytic viral therapy (1)
- oncolytic virus (1)
- one-health approach (1)
- organic farming (1)
- organization (1)
- organohalide respiration (1)
- organoid culture (1)
- organoids (1)
- origin (1)
- orthology (1)
- orthology network (1)
- ortsspezifische/homologe Rekombination (1)
- outbreak (1)
- outer membrane vesicles (1)
- outer-membrane proteins (1)
- oviedomycin (1)
- oxidative stress (1)
- p-Hydroxyphenylpyruvat-Dioxygenase (1)
- p-hydroxyphenylpyruvate dioxygenase (1)
- pangolin (1)
- par-seqFISH (1)
- parallel evolution (1)
- parasexual recombination (1)
- parasitology (1)
- paromomycin (1)
- pathogen (1)
- pathogen-associated molecular pattern (1)
- pathogene E. coli (1)
- pathogenesis (1)
- pathogenetic organism (1)
- pathogenic E. coli (1)
- pathogenic bacteria (1)
- pathogenicity island (1)
- pathogenicity island 2 (1)
- pathotypes (1)
- peptide (1)
- peptide conjugates (1)
- peptide transport (1)
- peptide tyrosine tyrosine (PYY) (1)
- peptide tyrosine tyrosine 3-36 (PYY\(_{3-36}\)) (1)
- peptido-glycan associated protein (1)
- permease (1)
- persistence (1)
- persister cells (1)
- phage induction (1)
- phagocytes (1)
- phagocytosis (1)
- phagosoms (1)
- pharmacokinetics (1)
- phased metamorphosis (1)
- phenotypic heterogeneity (1)
- phenotypic microarray (1)
- pheromones (1)
- phospholipase (1)
- phosphorylation (1)
- photooxidative stress (1)
- photosynthesis genes (1)
- phototrophic growth (1)
- phylogenetic analysis (1)
- phylogenetic trees (1)
- phytochemicals (1)
- pig farming methods (1)
- pigmentation (1)
- plant-made vaccines (1)
- plant-microbe interaction (1)
- plasmid characterization (1)
- plasmid-chromosome crosstalk (1)
- plasmodium (1)
- plastid targeting (1)
- platelet (1)
- point mutation (1)
- poly-(ADP-ribose)polymerase (1)
- polyadenylation sites (1)
- polycistronic transcription (1)
- polyketide (1)
- polyketide synthases (1)
- polymerase chain reaction (PCR) (1)
- poribacteria (1)
- porphyromonas gingivalis (1)
- positive selection (1)
- post-transcriptional regulation (1)
- post-transcriptionalregulation (1)
- posttranscriptional control (1)
- posttranscriptional regulation (1)
- ppl (1)
- pre-messenger RNA (1)
- privatization (1)
- promastigotes (1)
- promoters (1)
- prophage (1)
- protease (1)
- protease inhibitor (1)
- protein (1)
- protein HFQ (1)
- protein expressions (1)
- protein families database (1)
- protein kinase signaling cascade (1)
- protein synthesis (1)
- protein-RNA recognition (1)
- proteom (1)
- proteome (1)
- protozoan parasite (1)
- pseudomas aeruginosa (1)
- pulmonary (1)
- purification (1)
- pyrococcus furiosus (1)
- pyrophosphatase (1)
- quanititative proteomics (1)
- quinone (1)
- rRNA Prozessierung (1)
- rRNA depletion (1)
- rRNA processing (1)
- radiation-therapy (1)
- radioiodine therapy (1)
- ralstonia solanacearum (1)
- rat (1)
- receptor (1)
- receptors (1)
- reciprocal best hit (1)
- recombinant proteins (1)
- regionalization and organoids (1)
- regulatory small RNAs (1)
- remote sequence conservation (1)
- replication (1)
- reporter (1)
- repression (1)
- reputation (1)
- resistance mechanism (1)
- resistance-breaking properties (1)
- resistant Staphylococcus-aureus (1)
- restenosis (1)
- reveals (1)
- rhodobacter sphaeroides (1)
- ribosomal RNA (1)
- rotavirus (1)
- sRNA atlas (1)
- sRNA biogenesis (1)
- salmonella (1)
- salmonella enterica (1)
- sationary phase (1)
- scaffold protein (1)
- schistosoma (1)
- schistosomula (1)
- scholarly publishing (1)
- scientific publishing (1)
- screening (1)
- secondary structure (1)
- secreted aspartic proteases (1)
- secreted aspartic proteinase (1)
- secreted proteins (1)
- secretome (1)
- segmentation (1)
- sekretierte Proteine (1)
- sekretorische Aspartylprotease (1)
- selectionmarker (1)
- selectivity (1)
- sequence motif analysis (1)
- sequences (1)
- sequencing protocol (1)
- ser/thr kinase (1)
- serine protease (1)
- serotonin (1)
- serovar Typhimurium (1)
- serum resistance (1)
- sexual stage (1)
- sexual stage surface proteins (1)
- sexual stages (1)
- sfaA gene) (1)
- shiga toxin (1)
- shiga toxin 2 (1)
- shock sigma factor (1)
- siRNA (1)
- siRNAs (1)
- sigma factor (1)
- signal-transduction systems (1)
- signaling network (1)
- signaltransduction (1)
- simultaneous (1)
- single cell genomics (1)
- singlet oxygen stress (1)
- sinorhizobium fredii NGR234 (1)
- site-specific/homologous recombination (1)
- skin fatty acid (1)
- small interfering RNAs (1)
- small non-coding RNAs (1)
- small noncoding RNAs (1)
- small proteins (1)
- small regulatory RNAs (1)
- sodium-iodide symporter (1)
- solubility (1)
- soluble-RNA (1)
- soluble-RNAs (1)
- sortase A (1)
- specificity (1)
- sponge (1)
- sponges (1)
- spores (1)
- stability (1)
- stage-i (1)
- staib agar (1)
- staphilococci (1)
- staphylocccal infection/epidemiology (1)
- staphylococcal abscess (1)
- staphylococci (1)
- staphylococcus (1)
- stationary phase (1)
- stomach (1)
- strain (1)
- strain Newman (1)
- streptococcus pneumoniae (1)
- stress resistance (1)
- stress response (1)
- stringency (1)
- structural elucidation (1)
- structural modification (1)
- structure activity (1)
- structure-activity relationship (1)
- structure–activity (1)
- subcellular localization (1)
- subinhibitorische Antibiotikakonzentrationen (1)
- subinhibitory antibiotikkonzentrations (1)
- subpopulation (1)
- subtilis genome (1)
- sulfates (1)
- sulfur (1)
- suppressor mutation (1)
- surgery (1)
- symbiosis (1)
- synthetase (1)
- tag based (1)
- tandem mass-spectra (1)
- target (1)
- target recognition (1)
- tetrachloroethene (1)
- thiostrepton (1)
- thymyl cinnamate (1)
- thyroid-cancer (1)
- tobacco (1)
- toll-like receptor 2 (1)
- topical treatment (1)
- toxin (1)
- trans-activation (1)
- transcription factor (1)
- transcription initiation site (1)
- transcription regulator (1)
- transcription start site (1)
- transcription start sites (1)
- transcriptional control (1)
- transcriptional landscape (1)
- transcriptional regulation (1)
- transcriptional regulator (1)
- transcriptional start site (1)
- transcriptional uni (1)
- transcriptom (1)
- transcriptomeanalysis (1)
- transfection (1)
- transfer (1)
- transfer RNA (1)
- transkiptome (1)
- translation initiation (1)
- translational initiation (1)
- translocation (1)
- transmission blocking vaccine (1)
- transmission blocking vaccines (1)
- transport (1)
- transport systems (1)
- transporter (1)
- transposable elements (1)
- transposase (1)
- transposition (1)
- transposon (1)
- tuberculosis (1)
- two-component systems (1)
- two‐component system (1)
- type 1 fimbriae (1)
- type III protein secretion system complex (1)
- type III secretion system pathways (1)
- tyrosine kinase (1)
- ubiquitin (1)
- ulcreative colitis (1)
- untranslated regions (1)
- urinary tract infection (UTI) (1)
- urinary-tract-infection (1)
- uropathogene Escherichia coli (UPEC) (1)
- uropathogener E. coli Stamm 536 (1)
- uropathogenic E. coli strain 536 (1)
- uropathogenic Escherichia coli (1)
- uropathogenic Escherichia coli (UPEC) (1)
- uropathogenicity (1)
- uropathogens (1)
- vaccine (1)
- vaccines (1)
- vacuole (1)
- vacuoles (1)
- variant surface glycoprotein (1)
- version control (1)
- vertical transmission (1)
- vibrio parahaemolyticus (1)
- viral protein-R (1)
- viral replication (1)
- virotherapy (1)
- virulence genes (1)
- virulence mechanisms (1)
- virulence modulation (1)
- virulence-associated genes (1)
- virus-infection (1)
- visceral leishmaniasis (1)
- wikis (1)
- workflow platform (1)
- xanthomonas (1)
- xanthomonas campestris (1)
- xanthomonas maltophilia (1)
- yeast (1)
- yvcK/glmR operon (1)
- zinc cluster transcription factor (1)
- zirkuläre Intermediate (1)
- zoonotic (1)
- zoonotic risk (1)
- Ökologie (1)
- Ökosystem (1)
- Übertrag (1)
- äußere Membranvesikel (1)
Institute
- Institut für Molekulare Infektionsbiologie (427)
- Graduate School of Life Sciences (33)
- Rudolf-Virchow-Zentrum (13)
- Theodor-Boveri-Institut für Biowissenschaften (13)
- Lehrstuhl für Biochemie (9)
- Institut für Hygiene und Mikrobiologie (7)
- Institut für Pharmazie und Lebensmittelchemie (7)
- Klinik und Poliklinik für Allgemein-, Viszeral-, Gefäß- und Kinderchirurgie (Chirurgische Klinik I) (5)
- Lehrstuhl für Tissue Engineering und Regenerative Medizin (5)
- Physikalisches Institut (5)
Sonstige beteiligte Institutionen
- Universitätsklinikum Münster (2)
- Genelux Corporation, San Diego Science Center, 3030 Bunker Hill Street, Suite 310, San Diego, California 92109, USA (1)
- Helmholtz Center for RNA-based Infection Research (1)
- Institut für Molekulare Infektionsbiologie (MIB) der Universität Würzburg (1)
- MRB Forschungszentrum für Magnet-Resonanz-Bayern e.V., Am Hubland, D-97074 Würzburg (1)
- Research Center for Infectious Diseases (ZINF), University of Wuerzburg, Wuerzburg, Germany, (1)
- Research Center of Infectious Diseases (ZINF) of the University of Wurzburg, Germany (1)
- Zentrum für Infektionsforschung (ZINF): Nachwuchsgruppe 2 (1)
Background: Searching the orthologs of a given protein or DNA sequence is one of the most important and most commonly used Bioinformatics methods in Biology. Programs like BLAST or the orthology search engine Inparanoid can be used to find orthologs when the similarity between two sequences is sufficiently high. They however fail when the level of conservation is low. The detection of remotely conserved proteins oftentimes involves sophisticated manual intervention that is difficult to automate.
Results: Here, we introduce morFeus, a search program to find remotely conserved orthologs. Based on relaxed sequence similarity searches, morFeus selects sequences based on the similarity of their alignments to the query, tests for orthology by iterative reciprocal BLAST searches and calculates a network score for the resulting network of orthologs that is a measure of orthology independent of the E-value. Detecting remotely conserved orthologs of a protein using morFeus thus requires no manual intervention. We demonstrate the performance of morFeus by comparing it to state-of-the-art orthology resources and methods. We provide an example of remotely conserved orthologs, which were experimentally shown to be functionally equivalent in the respective organisms and therefore meet the criteria of the orthology-function conjecture.
Conclusions: Based on our results, we conclude that morFeus is a powerful and specific search method for detecting remotely conserved orthologs.
Epstein-Barr virus (EBV) is best known for infection of B cells, in which it usually establishes an asymptomatic lifelong infection, but is also associated with the development of multiple B cell lymphomas. EBV also infects epithelial cells and is associated with all cases of undifferentiated nasopharyngeal carcinoma (NPC). EBV is etiologically linked with at least 8% of gastric cancer (EBVaGC) that comprises a genetically and epigenetically distinct subset of GC. Although we have a very good understanding of B cell entry and lymphomagenesis, the sequence of events leading to EBVaGC remains poorly understood. Recently, ephrin receptor A2 (EPHA2) was proposed as the epithelial cell receptor on human cancer cell lines. Although we confirm some of these results, we demonstrate that EBV does not infect healthy adult stem cell-derived gastric organoids. In matched pairs of normal and cancer-derived organoids from the same patient, EBV only reproducibly infected the cancer organoids. While there was no clear pattern of differential expression between normal and cancer organoids for EPHA2 at the RNA and protein level, the subcellular location of the protein differed markedly. Confocal microscopy showed EPHA2 localization at the cell-cell junctions in primary cells, but not in cancer cell lines. Furthermore, histologic analysis of patient tissue revealed the absence of EBV in healthy epithelium and presence of EBV in epithelial cells from inflamed tissue. These data suggest that the EPHA2 receptor is not accessible to EBV on healthy gastric epithelial cells with intact cell-cell contacts, but either this or another, yet to be identified receptor may become accessible following cellular changes induced by inflammation or transformation, rendering changes in the cellular architecture an essential prerequisite to EBV infection.
Background: Recent data suggest that cancer stem cells (CSCs) play an important role in cancer, as these cells possess enhanced tumor-forming capabilities and are responsible for relapses after apparently curative therapies have been undertaken. Hence, novel cancer therapies will be needed to test for both tumor regression and CSC targeting. The use of oncolytic vaccinia virus (VACV) represents an attractive anti-tumor approach and is currently under evaluation in clinical trials. The purpose of this study was to demonstrate whether VACV does kill CSCs that are resistant to irradiation and chemotherapy.
Methods: Cancer stem-like cells were identified and separated from the human breast cancer cell line GI-101A by virtue of increased aldehyde dehydrogenase 1 (ALDH1) activity as assessed by the ALDEFLUOR assay and cancer stem cell-like features such as chemo-resistance, irradiation-resistance and tumor-initiating were confirmed in cell culture and in animal models. VACV treatments were applied to both ALDEFLUOR-positive cells in cell culture and in xenograft tumors derived from these cells. Moreover, we identified and isolated CD44\(^+\)CD24\(^+\)ESA\(^+\) cells from GI-101A upon an epithelial-mesenchymal transition (EMT). These cells were similarly characterized both in cell culture and in animal models.
Results: We demonstrated for the first time that the oncolytic VACV GLV-1h68 strain replicated more efficiently in cells with higher ALDH1 activity that possessed stem cell-like features than in cells with lower ALDH1 activity. GLV-1h68 selectively colonized and eventually eradicated xenograft tumors originating from cells with higher ALDH1 activity. Furthermore, GLV-1h68 also showed preferential replication in CD44\(^+\)CD24\(^+\)ESA\(^+\) cells derived from GI-101A upon an EMT induction as well as in xenograft tumors originating from these cells that were more tumorigenic than CD44\(^+\)CD24\(^-\)ESA\(^+\) cells.
Conclusions: Taken together, our findings indicate that GLV-1h68 efficiently replicates and kills cancer stem-like cells. Thus, GLV-1h68 may become a promising agent for eradicating both primary and metastatic tumors, especially tumors harboring cancer stem-like cells that are resistant to chemo and/or radiotherapy and may be responsible for recurrence of tumors.
Bakterielle Aufnahme, Selektivität und interne Prozessierung bei marinen Schwämmen (Porifera)
(2006)
Marine Schwämme (Porifera) gelten als die evolutionär ältesten Metazoen. Sie sind in allen Meeren verbreitet und tragen einen großen Anteil zur Invertebraten-Fauna bei. Ihrer Lebens-weise als Filtrierer entsprechend pumpen Schwämme bis zu 23.000 l Seewasser Kg-1 Schwamm Tag-1. Das enthaltene Bakterioplankton wird mit hoher Effizienz ausgefiltert und dient als Nahrung. Gleichzeitig enthalten einige Schwammspezies eine sehr hohe Anzahl phylogenetisch diverser Bakterien extrazellulär in der Mesohylmatrix, die bis zu 40% der Gesamtbiomasse ausmachen. Die als Symbionten bezeichnete Bakteriengemeinschaft weist eine hochgradig spezifische phylogenetische Zusammensetzung auf, die bei unterschiedlichen Schwammspezies, jedoch nicht im Seewasser oder Sediment, gefunden wird. Im Rahmen dieser Dissertationsarbeit wurden unterschiedliche Muster der Bakterien-haltigkeit mariner Schwämme durch Elektronenmikroskopie beschrieben. Die Gruppe der bakterienhaltigen Schwämme wies eine hohe Anzahl von Mikroben im Mesohyl auf. Aufgrund der bakteriellen Verteilung wurde zwischen stark und intermediär bakterienhaltigen Spezies unterschieden. Stark bakterienhaltige Schwämme zeigten eine gleichmäßig dichte Verteilung der Mikroben im Mesohyl, die Bakterienkonzentrationen lagen bei 109 - 1010 Zel-len g-1 Schwamm. Intermediär bakterienhaltige Schwämme enthielten lokale Anhäufungen von Mikroben, die in allen Stellen des Tieres gefunden wurden. Die Zellzahlen lagen bei 108 – 109 Bakterien g-1 Schwamm. Die Gruppe der bakterienarmen Schwämme wurde durch ein mikroskopisch bakterienfreies Mesohyl charakterisiert, die Bakterienkonzentrationen betrugen ~106 Zellen g-1 Schwamm und waren damit vergleichbar zu natürlichem Seewasser. In Korrelation zum Bakteriengehalt wurden anatomische Unterschiede des Gewebes beider Schwammgruppen beobachtet. Die bakterielle Aufnahme von Schwämmen wurde an einzelnen Individuen in Filtra-tionsexperimenten untersucht. Es wurde die Aufnahme des „Futterbakteriums“ Vibrio sp. SB177 und des schwammspezifischen Symbiontenkonsortiums gemessen. Die bakterien-haltigen Schwämme Aplysina aerophoba und Chondrosia reniformis wiesen im Vergleich zu „Futterbakterien“ eine sehr stark verminderte Aufnahme gegenüber ihren eigenen Symbionten auf, bei A. aerophoba sank die Filtrationsrate von rn = 2,76 x 106 auf 5,47 x 104 Bakterien g-1 Schwamm h-1. Die bakterienarmen Schwämme Dysidea avara und Tethya aurantium zeigten eine effiziente und undifferenzierte Aufnahme gegenüber allen Mikroben. Das nur bei bak-terienhaltigen Schwämmen gefundene Muster der stark verminderten Aufnahme von Symbi-onten ist statistisch signifikant. Untersuchungen zum Einfluss abdaubarer bakterieller Zell-wandproteine und der bakteriellen Flagelle erbrachten keine Hinweise auf eine Beteiligung dieser Faktoren am bakteriellen Filtrationsprozess der Schwämme. Zur Untersuchung einer möglichen Filtrationsselektivität gegenüber bestimmten bak-teriellen Vertretern des Seewasser- und des Symbiontenkonsortiums wurden Filtrationsexperi-mente durchgeführt. Proben des Inkubationswassers wurde während des Experiments entnom-men und die phylogenetische Zusammensetzung der Konsortien mittels Denaturierender Gradienten Gel Elektrophorese (DGGE) untersucht. Die Banden wurden anhand der Stärke über den zeitlichen Verlauf klassifiziert. Von den anfänglich 40 nachweisbaren Banden des Seewasserkonsortiums wurden nach 300 Minuten experimenteller Dauer eine als konstant, 18 als reduziert und 21 als verschwindend eingeordnet. Für das Symbiontenkonsortium wurden von den initial 65 Banden nach 300 Minuten 30 Banden als konstant, 19 als reduziert und 16 als verschwindend klassifiziert. Während für das Seewasserkonsortium eine Aufnahme fast aller bakterieller Phylotypen überwog, unterlagen nur wenige Phylotypen des Symbionten-konsortiums einer starken Aufnahme. Durch Sequenzierung und phylogenetische Zuordnung repräsentativer Banden wurde gezeigt, dass für die bakterielle Aufnahme keine Selektivität gegenüber einer bestimmten phylogenetischen Abstammungslinie besteht. So wurden z. B. Phylotypen der Chloroflexi als konstant, reduziert, als auch verschwindend beurteilt. Die interne Prozessierung und der Transport aufgenommener Partikel und Bakterien im Mesohyl wurde mikroskopisch untersucht. A. aerophoba transportierte große Aggregate aufgenommener Latex Beads in speziellen Schwammzellgruppen durch das Mesohyl. Es konnte keine Abgabe der Beads in die extrazelluläre Matrix (ECM) beobachtet werden. D. avara transportierte einzelne Beads durch das Mesohyl, nach 300 Minuten wurden zahlreiche Beads in der ECM gefunden. Die bakterielle Aufnahme wurde an dem GFP-exprimierenden „Futterbakterium“ Vibrio sp. MMW1 visualisiert. Die Bakterien wurden mit hoher Effizienz von A. aerophoba aufgenommen, konnten jedoch nicht in tieferen Mesohylbereichen nach-gewiesen werden, was auf eine zügige Lyse der Zellen hindeutete. Fluoreszenzmarkierte Symbiontenzellen wurden nicht von A. aerophoba aber, in Übereinstimung mit den Filtrationsexperimenten, von dem bakterienarmen D. avara aufgenommen. Die Ergebnisse belegen, dass bakerienhaltige Schwämme über einen komplexen Mechanismus der bakteriellen Aufnahme verfügen, durch den zwischen Futterbakterien und Symbionten unterschieden wird. Schwämme stellen deshalb ein interessantes Modellsystem zur Untersuchung von Mechanismen der generellen Phagozytose und der gleichzeitigen Tolerierung von symbiontischen Bakterienzellen im Gewebe dar.
Background
Oncolytic virotherapy of tumors is an up-coming, promising therapeutic modality of cancer therapy. Unfortunately, non-invasive techniques to evaluate the inflammatory host response to treatment are rare. Here, we evaluate \(^{19}\)F magnetic resonance imaging (MRI) which enables the non-invasive visualization of inflammatory processes in pathological conditions by the use of perfluorocarbon nanoemulsions (PFC) for monitoring of oncolytic virotherapy.
Methodology/Principal Findings
The Vaccinia virus strain GLV-1h68 was used as an oncolytic agent for the treatment of different tumor models. Systemic application of PFC emulsions followed by \(^1H\)/\(^{19}\)F MRI of mock-infected and GLV-1h68-infected tumor-bearing mice revealed a significant accumulation of the \(^{19}\)F signal in the tumor rim of virus-treated mice. Histological examination of tumors confirmed a similar spatial distribution of the \(^{19}\)F signal hot spots and \(CD68^+\)-macrophages. Thereby, the \(CD68^+\)-macrophages encapsulate the GFP-positive viral infection foci. In multiple tumor models, we specifically visualized early inflammatory cell recruitment in Vaccinia virus colonized tumors. Furthermore, we documented that the \(^{19}\)F signal correlated with the extent of viral spreading within tumors.
Conclusions/Significance
These results suggest \(^{19}\)F MRI as a non-invasive methodology to document the tumor-associated host immune response as well as the extent of intratumoral viral replication. Thus, \(^{19}\)F MRI represents a new platform to non-invasively investigate the role of the host immune response for therapeutic outcome of oncolytic virotherapy and individual patient response.
Background: In principle, the elimination of malignancies by oncolytic virotherapy could proceed by different mechanisms - e.g. tumor cell specific oncolysis, destruction of the tumor vasculature or an anti-tumoral immunological response. In this study, we analyzed the contribution of these factors to elucidate the responsible mechanism for regression of human breast tumor xenografts upon colonization with an attenuated vaccinia virus (VACV). Methods: Breast tumor xenografts were analyzed 6 weeks post VACV infection (p.i.; regression phase) by immunohistochemistry and mouse-specific expression arrays. Viral-mediated oncolysis was determined by tumor growth analysis combined with microscopic studies of intratumoral virus distribution. The tumor vasculature was morphologically characterized by diameter and density measurements and vessel functionality was analyzed by lectin perfusion and extravasation studies. Immunological aspects of viral-mediated tumor regression were studied in either immune-deficient mouse strains (T-, B-, NK-cell-deficient) or upon cyclophosphamide-induced immunosuppression (MHCII+-cell depletion) in nude mice. Results: Late stage VACV-infected breast tumors showed extensive necrosis, which was highly specific to cancer cells. The tumor vasculature in infected tumor areas remained functional and the endothelial cells were not infected. However, viral colonization triggers hyperpermeability and dilatation of the tumor vessels, which resembled the activated endothelium in wounded tissue. Moreover, we demonstrated an increased expression of genes involved in leukocyte-endothelial cell interaction in VACV-infected tumors, which orchestrate perivascular inflammatory cell infiltration. The immunohistochemical analysis of infected tumors displayed intense infiltration of MHCII-positive cells and colocalization of tumor vessels with MHCII+/CD31+ vascular leukocytes. However, GI-101A tumor growth analysis upon VACV-infection in either immunosuppressed nude mice (MHCII+-cell depleted) or in immune-deficient mouse strains (T-, B-, NK-cell-deficient) revealed that neither MHCII-positive immune cells nor T-, B-, or NK cells contributed significantly to VACV-mediated tumor regression. In contrast, tumors of immunosuppressed mice showed enhanced viral spreading and tumor necrosis. Conclusions: Taken together, these results indicate that VACV-mediated oncolysis is the primary mechanism of tumor shrinkage in the late regression phase. Neither the destruction of the tumor vasculature nor the massive VACV-mediated intratumoral inflammation was a prerequisite for tumor regression. We propose that approaches to enhance viral replication and spread within the tumor microenvironment should improve therapeutical outcome.
Converging evidence suggests a role of serotonin (5-hydroxytryptamine, 5-HT) and tryptophan hydroxylase 2 (TPH2), the rate-limiting enzyme of 5-HT synthesis in the brain, in modulating long-term, neurobiological effects of early-life adversity. Here, we aimed at further elucidating the molecular mechanisms underlying this interaction, and its consequences for socio-emotional behaviors, with a focus on anxiety and social interaction. In this study, adult, male Tph2 null mutant (Tph2\(^{-/-}\)) and heterozygous (Tph2\(^{+/-}\)) mice, and their wildtype littermates (Tph2\(^{+/+}\)) were exposed to neonatal, maternal separation (MS) and screened for behavioral changes, followed by genome-wide RNA expression and DNA methylation profiling. In Tph2\(^{-/-}\) mice, brain 5-HT deficiency profoundly affected socio-emotional behaviors, i.e., decreased avoidance of the aversive open arms in the elevated plus-maze (EPM) as well as decreased prosocial and increased rule breaking behavior in the resident-intruder test when compared to their wildtype littermates. Tph2\(^{+/-}\) mice showed an ambiguous profile with context-dependent, behavioral responses. In the EPM they showed similar avoidance of the open arm but decreased prosocial and increased rule breaking behavior in the resident-intruder test when compared to their wildtype littermates. Notably, MS effects on behavior were subtle and depended on the Tph2 genotype, in particular increasing the observed avoidance of EPM open arms in wildtype and Tph2\(^{+/-}\) mice when compared to their Tph2\(^{-/-}\) littermates. On the genomic level, the interaction of Tph2 genotype with MS differentially affected the expression of numerous genes, of which a subset showed an overlap with DNA methylation profiles at corresponding loci. Remarkably, changes in methylation nearby and expression of the gene encoding cholecystokinin, which were inversely correlated to each other, were associated with variations in anxiety-related phenotypes. In conclusion, next to various behavioral alterations, we identified gene expression and DNA methylation profiles to be associated with TPH2 inactivation and its interaction with MS, suggesting a gene-by-environment interaction-dependent, modulatory function of brain 5-HT availability.
In dieser Arbeit wurde in Legionella pneumophila Corby ein bislang nicht in L. pneumophila beschriebener Bereich im Genom kloniert und sequenziert, der für ein putatives Konjugations- Typ IV Sekretionssystem kodiert. Alle für ein Typ IV Sekretionssystem notwendigen Gene sind vorhanden. Zum einen kodieren diese ein „mating pair formation“ System, also Proteine für die Pilusgenese und energieabhängigen Transport von Substraten aus der Bakterienzelle. Konjugationsexperimente zeigen, dass es sich bei den „DNA transfer and replication“ Genen trb/tra System um einen funktionierenden Mechanismus zur Mobilisierung von DNA handelt.
In Staphylococcus aureus, de novo methionine biosynthesis is regulated by a unique hierarchical pathway involving stringent-response controlled CodY repression in combination with a T-box riboswitch and RNA decay. The T-box riboswitch residing in the 5′ untranslated region (met leader RNA) of the S. aureus metICFE-mdh operon controls downstream gene transcription upon interaction with uncharged methionyl-tRNA. met leader and metICFE-mdh (m)RNAs undergo RNase-mediated degradation in a process whose molecular details are poorly understood. Here we determined the secondary structure of the met leader RNA and found the element to harbor, beyond other conserved T-box riboswitch structural features, a terminator helix which is target for RNase III endoribonucleolytic cleavage. As the terminator is a thermodynamically highly stable structure, it also forms posttranscriptionally in met leader/ metICFE-mdh read-through transcripts. Cleavage by RNase III releases the met leader from metICFE-mdh mRNA and initiates RNase J-mediated degradation of the mRNA from the 5′-end. Of note, metICFE-mdh mRNA stability varies over the length of the transcript with a longer lifespan towards the 3′-end. The obtained data suggest that coordinated RNA decay represents another checkpoint in a complex regulatory network that adjusts costly methionine biosynthesis to current metabolic requirements.
Methionine is the first amino acid of every newly synthesised protein. In combination with its role as precursor for the vital methyl-group donor S-adenosylmethionine, methionine is essential for every living cell. The opportunistic human pathogen Staphylococcus aureus is capable of synthesising methionine de novo, when it becomes scarce in the environment. All genes required for the de novo biosynthesis are encoded by the metICFE-mdh operon, except for metX. Expression is controlled by a hierarchical network with a methionyl-tRNA-specific T-box riboswitch (MET-TBRS) as centrepiece, that is also referred to as met leader (RNA). T-box riboswitches (TBRS) are regulatory RNA elements located in the 5’-untranslated region (5’-UTR) of genes. The effector molecule of T-box riboswitches is uncharged cognate tRNA. The prevailing mechanism of action is premature termination of transcription of the nascent RNA in the absence of the effector (i.e. uncharged cognate tRNA) due to formation of a hairpin structure, the Terminator stem. In presence of the effector, a transient stabilisation of the alternative structure, the Antiterminator, enables transcription of the downstream genes (‘read-through’). Albeit, after the read-through the thermodynamically more stable Terminator eventually forms. The Terminator and the Antiterminator are two mutually exclusive structures. Previous work of the research group showed that in staphylococci the MET-TBRS ensures strictly methionine-dependent control of met operon expression. Uncharged methionyl-tRNA that activates the system is only present in sufficient amounts under methionine-deprived conditions. In contrast to other bacterial TBRS, the staphylococcal MET-TBRS has some characteristic features regarding its length and predicted secondary structure whose relevance for the function are yet unkown.
Aim of the present thesis was to experimentally determine the structure of the met leader RNA and to investigate the stability of the met operon-specific transcripts in the context of methionine biosynthesis control. Furthermore, the yet unknown function of the mdh gene within the met operon was to be determined.
In the context of this thesis, the secondary structure of the met leader was determined employing in-line probing. The structural analysis revealed the presence of almost all highly conserved T-box riboswitch structural characteristics. Furthermore, three additional stems, absent in all T-box riboswitches analysed to date, could be identified. Particularly remarkable is the above average length of the Terminator stem which renders it a potential target of the double-strand-specific endoribonuclease III (RNase III). The RNase III-dependent cleavage of the met leader could be experimentally verified by the use of suitable mutants. Moreover, the exact cleavage site within the Terminator was determined.
The unusual immediate separation of the met leader from the met operon mRNA via the RNase III cleavage within the Terminator stem induces the rapid degradation of the met leader RNA and, most likely, that of the 5’-region of the met mRNA. The met mRNA is degraded from its 5’-end by the exoribonuclease RNase J. The stability of the met mRNA was found to vary over the length of the transcript with an instable 5’-end (metI and metC) and a longer half-life towards the 3’-end (metE and mdh). The varying transcript stability is reflected by differences in the available cellular protein levels. The obtained data suggest that programmed mRNA degradation is another level of regulation in the complex network of staphylococcal de novo methionine biosynthesis control.
In addition, the MET-TBRS was studied with regard to a future use as a drug target for novel antimicrobial agents. To this end, effects of a dysregulated methionine biosynthesis on bacterial growth and survival were investigated in met leader mutants that either caused permanent transcription of the met operon (‘ON’) or prevented operon transcription (‘OFF’), irrespective of the methionine status in the cell. Methionine deprivation turned out to be a strong selection pressure, as ‘OFF’ mutants acquired adaptive mutations within the met leader to restore met operon expression that subsequently re-enabled growth.
The second part of the thesis was dedicated to the characterisation of the Mdh protein that is encoded by the last gene of the met operon and whose function is unknown yet. At first, co-transcription and -expression with the met operon could be demonstrated. Next, the Mdh protein was overexpressed and purified and the crystal structure of Mdh was solved to high resolution by the Kisker research group (Rudolf-Virchow-Zentrum Würzburg). Analysis of the structure revealed the amino acid residues crucial for catalytic activity, and zinc was identified as a co-factor of Mdh. Also, Mdh was shown to exist as a dimer. However, identification of the Mdh substrate was, in the context of this thesis, (still) unsuccessful. Nevertheless, interactions of Mdh with enzymes of the met operon could be demonstrated by employing the bacterial two-hybrid system. This fact and the high conservation of mdh/Mdh on nucleotide and amino acid level among numerous staphylococcal species suggests an important role of Mdh within the methionine metabolism that should be a worthwhile subject of future research.
The infection of a eukaryotic host cell by a bacterial pathogen is one of the most intimate examples of cross-kingdom interactions in biology. Infection processes are highly relevant from both a basic research as well as a clinical point of view. Sophisticated mechanisms have evolved in the pathogen to manipulate the host response and vice versa host cells have developed a wide range of anti-microbial defense strategies to combat bacterial invasion and clear infections. However, it is this diversity and complexity that makes infection research so challenging to technically address as common approaches have either been optimized for bacterial or eukaryotic organisms. Instead, methods are required that are able to deal with the often dramatic discrepancy between host and pathogen with respect to various cellular properties and processes. One class of cellular macromolecules that exemplify this host-pathogen heterogeneity is given by their transcriptomes: Bacterial transcripts differ from their eukaryotic counterparts in many aspects that involve both quantitative and qualitative traits. The entity of RNA transcripts present in a cell is of paramount interest as it reflects the cell’s physiological state under the given condition. Genome-wide transcriptomic techniques such as RNA-seq have therefore been used for single-organism analyses for several years, but their applicability has been limited for infection studies.
The present work describes the establishment of a novel transcriptomic approach for infection biology which we have termed “Dual RNA-seq”. Using this technology, it was intended to shed light particularly on the contribution of non-protein-encoding transcripts to virulence, as these classes have mostly evaded previous infection studies due to the lack of suitable methods. The performance of Dual RNA-seq was evaluated in an in vitro infection model based on the important facultative intracellular pathogen Salmonella enterica serovar Typhimurium and different human cell lines. Dual RNA-seq was found to be capable of capturing all major bacterial and human transcript classes and proved reproducible. During the course of these experiments, a previously largely uncharacterized bacterial small non-coding RNA (sRNA), referred to as STnc440, was identified as one of the most strongly induced genes in intracellular Salmonella. Interestingly, while inhibition of STnc440 expression has been previously shown to cause a virulence defect in different animal models of Salmonellosis, the underlying molecular mechanisms have remained obscure. Here, classical genetics, transcriptomics and biochemical assays proposed a complex model of Salmonella gene expression control that is orchestrated by this sRNA. In particular, STnc440 was found to be involved in the regulation of multiple bacterial target mRNAs by direct base pair interaction with consequences for Salmonella virulence and implications for the host’s immune response. These findings exemplify the scope of Dual RNA-seq for the identification and characterization of novel bacterial virulence factors during host infection.
The transcriptome is a powerful proxy for the physiological state of a cell, healthy or diseased. As a result, transcriptome analysis has become a key tool in understanding the molecular changes that accompany bacterial infections of eukaryotic cells. Until recently, such transcriptomic studies have been technically limited to analyzing mRNA expression changes in either the bacterial pathogen or the infected eukaryotic host cell. However, the increasing sensitivity of high-throughput RNA sequencing now enables “dual RNA-seq” studies, simultaneously capturing all classes of coding and noncoding transcripts in both the pathogen and the host. In the five years since the concept of dual RNA-seq was introduced, the technique has been applied to a range of infection models. This has not only led to a better understanding of the physiological changes in pathogen and host during the course of an infection but has also revealed hidden molecular phenotypes of virulence-associated small noncoding RNAs that were not visible in standard infection assays. Here, we use the knowledge gained from these recent studies to suggest experimental and computational guidelines for the design of future dual RNA-seq studies. We conclude this review by discussing prospective applications of the technique.
FinO domain proteins such as ProQ of the model pathogen Salmonella enterica have emerged as a new class of major RNA-binding proteins in bacteria. ProQ has been shown to target hundreds of transcripts, including mRNAs from many virulence regions, but its role, if any, in bacterial pathogenesis has not been studied. Here, using a Dual RNA-seq approach to profile ProQ-dependent gene expression changes as Salmonella infects human cells, we reveal dysregulation of bacterial motility, chemotaxis, and virulence genes which is accompanied by altered MAPK (mitogen-activated protein kinase) signaling in the host. Comparison with the other major RNA chaperone in Salmonella, Hfq, reinforces the notion that these two global RNA-binding proteins work in parallel to ensure full virulence. Of newly discovered infection-associated ProQ-bound small noncoding RNAs (sRNAs), we show that the 3′UTR-derived sRNA STnc540 is capable of repressing an infection-induced magnesium transporter mRNA in a ProQ-dependent manner. Together, this comprehensive study uncovers the relevance of ProQ for Salmonella pathogenesis and highlights the importance of RNA-binding proteins in regulating bacterial virulence programs.
IMPORTANCE
The protein ProQ has recently been discovered as the centerpiece of a previously overlooked “third domain” of small RNA-mediated control of gene expression in bacteria. As in vitro work continues to reveal molecular mechanisms, it is also important to understand how ProQ affects the life cycle of bacterial pathogens as these pathogens infect eukaryotic cells. Here, we have determined how ProQ shapes Salmonella virulence and how the activities of this RNA-binding protein compare with those of Hfq, another central protein in RNA-based gene regulation in this and other bacteria. To this end, we apply global transcriptomics of pathogen and host cells during infection. In doing so, we reveal ProQ-dependent transcript changes in key virulence and host immune pathways. Moreover, we differentiate the roles of ProQ from those of Hfq during infection, for both coding and noncoding transcripts, and provide an important resource for those interested in ProQ-dependent small RNAs in enteric bacteria.
Motivation:
Next generation sequencing technologies have provided us with a wealth of information on genetic variation, but predi cting the functional significance of this variation is a difficult task. While many comparative genomics studies have focused on gene flux and large scale changes, relatively little attention has been paid to quantifying the effects of single nucleotide polymorphisms and indels on protein function, particularly in bacterial genomics.
Results:
We present a hidden Markov model based approach we call delta-bitscore (DBS) for identifying orthologous proteins that have diverged at the amino acid sequence level in a way that is likely to impact biological function. We benchmark this approach with several widely used datasets and apply it to a proof-of-concept study of orthologous proteomes in an investigation of host adaptation in Salmonella enterica. We highlight the value of the method in identifying functional divergence of genes, and suggest that this tool may be a better approach than the commonly used dN/dS metric for identifying functionally significant genetic changes occurring in recently diverged organisms.
Cutaneous leishmaniasis is initiated by the bite of an infected sandfly and inoculation of Leishmania major parasites into the mammalian skin. Macrophages are known to playa central role in the course of infection because they are the prime host cells and funetion as antigen-presenting eells (APC) for induetion of the eell-mediated immune response. However, in addition to maerophages in the dermis. the skin eontains epidermal Langerhans eells (LC) which ean present antigen (Ag) to T cells. Therefore, using a murine model of cutaneous leishmaniasis, we analyzed the ability of epidermal cells to induce a T eell response to L.major. The results demonstrated that freshly isolated LC, but not cuItured LC, are highly active in presenting L.major Ag in vitro to T cells from primed mice and to a L.major-specific T cell clone. Furthermore, freshly isolated LC had the ability to retain L.major Ag in immunogenic form for at least 2 days. Their efficiency was much greater than that of irradiated spleen cells, a standard population of APC. LC stimulated both T cell proliferation and production of the Iymphokines interleukin (IL)-2 and IL-4. The response was Ag specific and could be induced by lysate of L. major parasites and by live organisms. The data suggest that epidermal LC are important APC in eutaneous leishmaniasis. They may perform a critical funetion by eapturing L.major Ag in the skin and presenting it either to quiescent T eells circulating through the draining lymph node or locally to T effector cells infiltrating the cutaneous lesion.
Agrobacterium species are capable of interkingdom gene transfer between bacteria and plants. The genome of Agrobacterium tumefaciens consists of a circular and a linear chromosome, the At-plasmid and the Ti-plasmid, which harbors bacterial virulence genes required for tumor formation in plants. Little is known about promoter sequences and the small RNA (sRNA) repertoire of this and other α-proteobacteria. We used a differential RNA sequencing (dRNA-seq) approach to map transcriptional start sites of 388 annotated genes and operons. In addition, a total number of 228 sRNAs was revealed from all four Agrobacterium replicons. Twenty-two of these were confirmed by independent RNA gel blot analysis and several sRNAs were differentially expressed in response to growth media, growth phase, temperature or pH. One sRNA from the Ti-plasmid was massively induced under virulence conditions. The presence of 76 cis-antisense sRNAs, two of them on the reverse strand of virulence genes, suggests considerable antisense transcription in Agrobacterium. The information gained from this study provides a valuable reservoir for an in-depth understanding of sRNA-mediated regulation of the complex physiology and infection process of Agrobacterium.
Saposin-ähnliche Proteine (SAPLIPs) sind membraninteragierende Proteine, die sich durch die konservierte Position von drei Disulfidbrücken, einer typischen alpha-helikalen Proteinfaltung und der Fähigkeit mit Lipiden zu interagieren, auszeichnen. Ihre zellulären Funktionen sind äußerst vielfältig. Bis zum Beginn des Genomsequenzierungsprojektes waren die Amoebapores die einzigen bekannten und charakterisierten SAPLIPs von Entamoeba histolytica, dem Erreger der humanen Amöbenruhr. Aufgrund ihrer antimikrobiellen Aktivität stellen sie für diesen parasitischen Einzeller, der sich von phagozytierten Bakterien ernährt, wichtige Effektormoleküle dar. Sie können aber auch cytolytisch auf Wirtszellen wirken und werden deshalb als bedeutender Pathogenitätsfaktor angesehen. Die theoretische computergestützte Datenbankanalyse nach Abschluss der Genomsequenzierung ergab, dass es 16 weitere Gene kodierend für SAPLIPs zusätzlich zu den drei Amoebapore-Genen gibt. Die Sequenzen der neuen SAPLIPs sind abgesehen von dem Cysteinmotiv divers und auch die Größe der Proteine ist sehr unterschiedlich (77 - 1009 Aminosäuren). Alle besitzen sie jedoch eine einzige, C-terminal gelegene SAPLIP Domäne. Außer der SAPLIP-Domäne konnten keine weiteren bekannten funktionellen oder strukturellen Domänen in den relevanten Datenbanken identifiziert werden, die auf mögliche Funktionen hätten hinweisen können. Alle SAPLIP-Gene werden gleichzeitig in axenisch kultivierten Trophozoiten transkribiert wie durch reverse Transkriptions-PCR gezeigt wurde. Die vergleichende transkriptionelle Analyse im Mikroarray ergab, dass nach Kontakt mit menschlichen Kolonzellen keine Hochregulierung dieser Gene mit Ausnahme des Amoebapore A Gens stattfindet. Für die parallele Klonierung der verschiedenen SAPLIP-Domänen wurde ein ”Expressionsscreening” in E.coli mit dem grün fluoreszierenden Protein als Reporterprotein etabliert, das die erfolgreiche Klonierung und Expression eines Fragments aufgrund der Fluoreszenz der Bakterienkolonie bereits auf der Ebene der Transformation anzeigt. Die rekombinant exprimierte und bis zur Homogenität gereinigte SAPLIP-Domäne von SAPLIP 12 wies Amoebapore-ähnliche Aktivitäten auf. Unter Verwendung von Liposomen konnte porenbildende Aktivität nachgewiesen werden, wobei diese Aktivität stark an einen sauren pH-Wert gebunden ist. Die SAPLIP-Domäne 12 ist aber auch antibakteriell und dieses sogar mit vergleichbarer Selektivität wie Amoebapore A, nämlich Zelllyse von gram-positiven B. megaterium war nachweisbar, jedoch nicht von gram-negativen E. coli. Strukturell unterscheiden sich die SAPLIP-Domäne 12 und Amoebapore A bezüglich der Exposition positiver Ladungsansammlungen auf der Proteinoberfläche und des Fehlens des für den Mechanismus der Amoebapores essentiellen Histidinrestes an entsprechender Position in der Sequenz. Darüber hinaus übt die SAPLIP-Domäne 12 eine im Vergleich zum Amoebapore A geringere spezifische Aktivität aus. Diese Eigenschaften weisen darauf hin, dass es sich um einen anderen Wirkungsmechanismus handeln könnte. Für die SAPLIP-Domäne 12 wäre eine über die positiven Ladungen der Proteinoberfläche vermittelte Interaktion mit den negativ geladenen Phospholipidköpfen von Membranen denkbar, die bei Erreichen einer bestimmten Konzentration in einer Störung der Lipidordnung und letztendlich in der Auflösung der Membranstruktur resultieren könnte. SAPLIP 3 ähnelt den Amoebapores in der Größe und molekularen Architektur und kann somit als funktionelle Einheit angesehen werden, es unterscheidet sich aber durch eine hohe negative Nettoladung von den Amoebapores. Außerdem ist das rekombinante SAPLIP 3 nicht antibakteriell und die Membraninteraktionen dieses SAPLIPs unterscheiden sich grundlegend von denjenigen, die für die Amoebapores beschrieben sind. SAPLIP 3 zerstört nicht einfach die Liposomenstruktur wie von den porenbildenden Amoebapores bekannt, sondern es vermittelt die Fusion von multilamellaren Liposomen unter Freisetzung des Liposomeninhalts. Diese Aktivität ist abhängig von der Anwesenheit anionischer Lipide und von einem sauren pH-Wert. Die Fähigkeit zur Vesikelfusion sowie die Verteilung der negativen Ladungen von SAPLIP 3 auf der Proteinoberfläche ähneln Merkmalen des humanen Saposin C. Neben der Funktion als Cofaktor von Exohydrolasen, die im Sphingolipid Katabolismus involviert sind, wird angenommen, dass die Fähigkeit von Saposin C, Vesikel zu fusionieren, wichtig für die Reorganisation der humanen lysosomalen Kompartimente ist. Die Saposin C-ähnlichen Charakteristika von SAPLIP 3 geben Grund zu der Annahme, dass es bereits in einem so basalen Organismus wie der Amöbe ein Protein mit Saposin-ähnlichen membranfusionierenden Aktivitäten gibt und dass dieses SAPLIP entsprechende Funktionen während endo- und exozytotischer Transportprozesse in der Amöbe übernehmen könnte.
Die MHK-Werte von Desacetylcefotaxim gegen verschiedene, z. T. ampicillinresistente Stämme von Escherichia coH, die mit Hilfe einer Agardilutionsmethode erhoben wurden, waren höher als die von Cefotaxim und Ceftriaxon, jedoch niedriger als die von Cefoxitin. In einem Modell der systemischen Infektion der Maus mit einem plasmidtragenden, betalactamaseproduzierenden Stamm von E. coli führte die Therapie mit Desacetylcefotaxim zu einer starken Reduktion der Keime pro Leber. Im Vergleich zur Therapie mit Cefotaxim trat die protektive Wirkung aber verlangsamt ein. Desacetylcefotaxim ist also kein unnützes Abbauprodukt von Cefotaxim.
The massive remodeling of the heart tissue, as observed in response to pressure overload or myocardial infarction, is considered to play a causative role in the development of heart failure. Alterations in the heart architecture clearly affect the mechanical properties of the heart muscle, but they are rooted in changes at the cellular level including modulation of gene expression. Together with integrins, the transmembrane receptors linking the extracellular environment to the cytoskeleton, extracellular matrix (ECM) proteins and matricellular proteins are key components of the remodeling process in the heart. Therefore, this thesis was aimed at analysing the role of integrins in the regulation of gene expression and heart muscle performance during cardiac wound repair induced by pressure overload or myocardial infarction (MI). To investigate the contribution of integrin Beta 1, we characterised the response of mice with a conditional, cardiac-specific deletion of the integrin Beta 1 gene in an experimental model of pressure overload by aortic banding (AB). In particular, we measured physiological alterations and gene expression events in the stressed heart in the presence or absence of integrin Beta 1. Interestingly, mice containing a knock-out allele and the ventricular myocyte-specific conditional allele of the integrin Beta 1 gene were born and grew up to adulthood. Though these animals still exhibited minor amounts of integrin Beta1 in the heart (expressed by non-myocytes), these mice displayed abnormal cardiac function and were highly sensitive to AB. Whereas a compensatory hypertrophic response to pressure overload was observed in wildtype mice, the integrin Beta 1-deficient mice were not able to undergo heart tissue remodeling. Furthermore, ECM gene expression was altered and, in particular, the increased expression of the matricellular protein SPARC after AB was abolished in integrin Beta 1–deficient mice. Interestingly, we also found a transient upregulation of SPARC mRNA during heart remodeling after MI using cDNA macroarrays. Indeed, increased SPARC protein levels were observed starting at day 2 (2.55±0.21fold, p<0.01), day 7 (3.72±0.28 fold, p<0.01) and 1 month (1.9±0.16 fold, p<0.01) after MI, which could be abolished by using an integrin alpha v inhibitor in vivo. Immunofluorescence analysis of heart tissue demonstrated that the increased SPARC expression was confined to the infarcted area and occurred together with the influx of fibroblasts into the heart. In vitro, either TGF-Beta 1 or PDGF-BB stimulated SPARC expression by fibroblasts. Inhibition of integrin alpha v did not interfere with TGF-Beta1 or PDGF induced SPARC secretion as determined by ELISA assays or Western blot. However, secretion of TGF-Beta1 and PDGF-BB by cardiomyocytes was induced by vitronectin, a ligand of integrin alpha v, and this response was blocked by the integrin alpga v inhibitor. Functionally, SPARC modulated the migratory response of fibroblasts towards ECM proteins suggesting that the local deposition of SPARC following MI contributes to scar formation. Taken together, our combined in vivo and in vitro data demonstrate that several integrin subunits play critical roles during tissue remodeling in the injured heart. Integrin-dependent gene expression events such as the upregulation of SPARC following MI are critical to orchestrate the healing response. These processes appear to involve complex cross-talk between different cell types such as cardiomyocytes and fibroblasts to allow for locally confined scar formation. The elucidation of the sophisticated interplay between integrins, matricellular proteins such as SPARC, and growth factors will undoubtedly provide us with a better and clinically useful understanding of the molecular mechanisms governing heart remodeling.
To understand the gene regulation of an organism of interest, a comprehensive genome annotation is essential. While some features, such as coding sequences, can be computationally predicted with high accuracy based purely on the genomic sequence, others, such as promoter elements or noncoding RNAs, are harder to detect. RNA sequencing (RNA-seq) has proven to be an efficient method to identify these genomic features and to improve genome annotations. However, processing and integrating RNA-seq data in order to generate high-resolution annotations is challenging, time consuming, and requires numerous steps. We have constructed a powerful and modular tool called ANNOgesic that provides the required analyses and simplifies RNA-seq-based bacterial and archaeal genome annotation. It can integrate data from conventional RNA-seq and differential RNA-seq and predicts and annotates numerous features, including small noncoding RNAs, with high precision. The software is available under an open source license (ISCL) at https://pypi.org/project/ANNOgesic/.
Bacteria lose or gain genetic material and through selection, new variants become fixed in the population. Here we provide the first, genome-wide example of a single bacterial strain’s evolution in different deliberately colonized patients and the surprising insight that hosts appear to personalize their microflora. By first obtaining the complete genome sequence of the prototype asymptomatic bacteriuria strain E. coli 83972 and then resequencing its descendants after therapeutic bladder colonization of different patients, we identified 34 mutations, which affected metabolic and virulence-related genes. Further transcriptome and proteome analysis proved that these genome changes altered bacterial gene expression resulting in unique adaptation patterns in each patient. Our results provide evidence that, in addition to stochastic events, adaptive bacterial evolution is driven by individual host environments. Ongoing loss of gene function supports the hypothesis that evolution towards commensalism rather than virulence is favored during asymptomatic bladder colonization.
Asymptomatische Bakteriurie (ABU) stellt eine bakterielle Infektion der Harnblase über einen langen Zeitraum dar, die häufig von Escherichia coli hervorgerufen wird, ohne dass typische Symptome einer Harnwegsinfektion auftreten. Um die Charakteristika von ABU E. coli Isolaten genauer zu untersuchen, wurden die Geno- und Phänotypen von 11 ABU-Isolaten verglichen. Außerdem wurden in mehreren aufeinanderfolgenden in vivo-Reisolaten des Modell-ABU Stammes 83972 die Veränderungen im Transkriptom, Proteom und Genom während einer langfristigen Persistenz in der menschlichen Blase charakterisiert. Schließlich wurde der Effekt des menschlichen Wirtes auf die bakterielle Adaptation durch einen Vergleich von in vitro- mit in vivo-kultivierten Stämmen abgeschätzt. ABU-Isolate stellt eine heterogene Gruppe von Organismen dar. Diese können den vier phylogenetischen Hauptgruppen von E. coli sowie unterschiedlichen klonalen Gruppen zugeordnet werden. Dementsprechend unterscheiden sie sich erheblich bezüglich der Zusammensetzung des Genomes, der Genomgröße und auch der Ausstattung mit UPEC-typischen Virulenz-assoziierten Genen. Multi-Lokus-Sequenz-Typisierung legt nahe, dass bestimmte ABU Stämme sich durch Genomreduktion aus UPEC Stämmen entwickelt haben, die eine Harnwegsinfektion mit charakteristischen Symptomen auslösen konnten. Folglich erlaubt die hohe Genomplastizität von E. coli keine generalisierte Betrachtung einzelner Isolate eines Klons. Genomreduktion über Punktmutationen, Genom-Reorganisation und Deletionen resultierte in der Inaktivierung einiger Gene, die für einige UPEC Virulenz-Faktoren kodieren. Dies stützt die Vorstellung, dass eine verminderte bakterielle Aktivierung der Entzündung der Wirtsschleimhaut den Lebensstil von ABU (bei diesen E. coli-)Isolaten fördert. Genregulation und genetische Diversität sind Strategien, die es Bakterien ermöglichen unter sich fortlaufend ändernden Bedingungen zu leben bzw. zu überleben. Um die anpassungsbedingten Veränderungen bei einem langfristigen Wachstum in der Blase zu untersuchen, wurden aufeinanderfolgende Reisolate, denen eine langfristige in vivo-Kolonisierung im menschlichen Wirt beziehungsweise eine in vitro-Kultivierung vorausgegangen ist, im Hinblick auf Veränderungen Genexpression und Genomorganisation analysiert. In diesem Zusammenhang konnte gezeigt werden, dass E. coli in der Lage ist, seine metabolischen Netzwerke verschiedenen Wachstumsbedingungen anzupassen und individuelle bakterielle Kolonisierungsstrategien entwickeln kann. Transkriptom- und Proteom-Analysen zeigten verschiedene metabolische Strategien zur Nährstoffbeschaffung und Energieproduktion bei untersuchten in vivo-Reisolaten vom Stamm 83972, die es ihnen ermöglichen, den Wirt zu kolonisieren. Das Zurückgreifen auf D-Serin, Deoxy- und Ribonucleoside sowie die bidirektionale Umwandlung zwischen Pentose und Glucuronat waren hoch-regulierte Stoffwechselwege, die die in vivo-Reisolate mit zusätzlicher Energie für ein effizientes Wachstum in der Blase versorgen. Zudem wurden in dieser Studie die Netzwerke für eine Reaktion auf Abwehrmechanismen des Wirtes erforscht: Erstmals wurde hier die Rolle der Klasse-III-Alkoholdehydrogenase AdhC, bekannt durch ihre Bedeutung bei der Entgiftung von Stickstoffmonoxid, bei der Wirtsantwort während einer asymptomatischen Bakteriurie gezeigt. Aufeinanderfolgende in vivo- und in vitro-Reisolate vom Stamm 83972 wurden ebenfalls bezüglich ihrer Genomstruktur analysiert. Einige Veränderungen in der Genomstruktur der aufeinanderfolgenden Reisolate, die von einer humanen Kolonisierungsstudie stammen, implizieren die Bedeutung einer Interaktion der Bakterien mit dem Wirt bei der Mikroevolution der Bakterien. Dagegen war die Genomstruktur von Reisolaten eines langfristigen in vitro-Kultivierungsexperiments, bei dem sich der Stamm 83972 ohne Wirtskontakt vermehrt hat, nicht von Veränderungen betroffen. Das legt nahe, dass die Immunantwort eine Genomplastizität fördert und somit eine treibende Kraft für den ABU Lebensstil und die Evolution im Harnwegstrakt ist.
Escherichia coli isolates of serotype 06: K5 are the most common causative agents of cystitis and pyelonephritis in adults. To answer the question, as to whether strains of this particular serotype represent one special clonal group, out of a collection of 34 serotype 06: K5 isolates [Zingler et al. ( 1990) Zentralbl. Bakteriol Mikrobiol Hyg [A] 274:372-381] 15 strains were selected andanalyzed in detail. The flagellar (H) antigen and the outer membrane protein (OMP) pattern were determined. Furtherserum resistance properties and the genetic presence and expression of other virulence factors, including hemolysin, aerobactin, P fimbriae, S/F1C fimbriae and type 1 fimbriae was evaluated. In~laddition the Xbalmacrorestriction pattern of ten representative isolates was elaborated and the fimbrial (F) antigentype ofthe P fimbriae was determined, to obtain the complete 0: K: H: F pattern. These analyses could clearly show that the 06: K5 isolates do not represent one clonal group. The Xbal-macrorestriction profiles were heterogeneaus and marked differences in the hybridization patterns, using virulenceassociated gene probes in Southern hybridization of long-range-separated genomic DNA, were observed among the strains. However, some of strains showed similarities in the genomic profiles, arguing for clonal groupings among the 06: K5 isolates. lnterstingly the strains grouped tagether exhibited the same fimbrial F typethat many indicate a coincidence of this phenotypic trait with clonality.
A total of 36 Escherichia coli urinary tract isolates (UTI) of serotype 06, with different combinations of capsule ( K) and flagellin ( H) antigens, were analysed according to the outer membrane pattern (OMP), serum resistance properties, mannose-resistant hemagglutination using various types of erythrocytes, and also for the genetic presence and the expression of Pfimbriae. S fimbriae/F1 C fimbriae, Type 1 fimbriae, aerobactin and hemolysin. Twenty selected strains were further analysed by pulsed field gel electrophoresis (PFGE), elaborating genomic profilas by Xba I cleavage and subsequent Southern hybridization to virulence-associated DNA probes. lt could be shown that 06 UTI isolates represent a highly heterogeneaus group of strains according to the occurrence and combination of these traits. Relatedness an the genetic and the phenotypic Ievei was found for some of the strains exhibiting the same 0: K: H: F serotype. DNA Iang-range mapping further indicated some interesting features, according to the copy number and the genomic linkage of virulence genes.
Microcin C (McC) is a peptide-nucleotide antibiotic produced by Escherichia coli cells harboring a plasmid-borne operon mccABCDE. The heptapeptide MccA is converted into McC by adenylation catalyzed by the MccB enzyme. Since MccA is a substrate for MccB, a mechanism that regulates the MccA/MccB ratio likely exists. Here, we show that transcription from a promoter located upstream of mccA directs the synthesis of two transcripts: a short highly abundant transcript containing the mccA ORF and a longer minor transcript containing mccA and downstream ORFs. The short transcript is generated when RNA polymerase terminates transcription at an intrinsic terminator located in the intergenic region between the mccA and mccB genes. The function of this terminator is strongly attenuated by upstream mcc sequences. Attenuation is relieved and transcription termination is induced when ribosome binds to the mccA ORF. Ribosome binding also makes the mccA RNA exceptionally stable. Together, these two effects-ribosome induced transcription termination and stabilization of the message-account for very high abundance of the mccA transcript that is essential for McC production. The general scheme appears to be evolutionary conserved as ribosome-induced transcription termination also occurs in a homologous operon from Helicobacter pylori.
Background
Differential RNA-sequencing (dRNA-seq) is indispensable for determination of primary transcriptomes. However, using dRNA-seq data to map transcriptional start sites (TSSs) and promoters genome-wide is a bioinformatics challenge. We performed dRNA-seq of Bradyrhizobium japonicum USDA 110, the nitrogen-fixing symbiont of soybean, and developed algorithms to map TSSs and promoters.
Results
A specialized machine learning procedure for TSS recognition allowed us to map 15,923 TSSs: 14,360 in free-living bacteria, 4329 in symbiosis with soybean and 2766 in both conditions. Further, we provide proteomic evidence for 4090 proteins, among them 107 proteins corresponding to new genes and 178 proteins with N-termini different from the existing annotation (72 and 109 of them with TSS support, respectively). Guided by proteomics evidence, previously identified TSSs and TSSs experimentally validated here, we assign a score threshold to flag 14 % of the mapped TSSs as a class of lower confidence. However, this class of lower confidence contains valid TSSs of low-abundant transcripts. Moreover, we developed a de novo algorithm to identify promoter motifs upstream of mapped TSSs, which is publicly available, and found motifs mainly used in symbiosis (similar to RpoN-dependent promoters) or under both conditions (similar to RpoD-dependent promoters). Mapped TSSs and putative promoters, proteomic evidence and updated gene annotation were combined into an annotation file.
Conclusions
The genome-wide TSS and promoter maps along with the extended genome annotation of B. japonicum represent a valuable resource for future systems biology studies and for detailed analyses of individual non-coding transcripts and ORFs. Our data will also provide new insights into bacterial gene regulation during the agriculturally important symbiosis between rhizobia and legumes.